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Highlights
• In total, 287 cuticular protein genes are annotated in Spodoptera litura genome.
• Most RR-1 and His-rich RR-2 CPs form a major cluster in S. litura chromosome 9
• Histidine-rich RR-2 CPs are greatly expanded in S. litura compared to Bombyx mori.
• RR-1 CP genes are mostly conserved among S. litura, B. mori, and Manduca sexta.
• His-rich RR-2 CP genes form species-specific clades in phylogenetic analysis.
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Major histidine-rich CP expansion in S. litura
 Green bracnhes:
His-rich RR-2 CPs
 His-ric RR-2 CPs:  B. mori: 54 S. litura: 91
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Spodoptera litura  23 
Abstract 24 
Insect cuticle is considered an adaptable and versatile building material with roles in 25 
the construction and function of exoskeleton. Its physical properties are varied, as the 26 
biological requirements differ among diverse structures and change during the life 27 
cycle of the insect. Although the bulk of cuticle consists basically of cuticular proteins 28 
(CPs) associated with chitin, the degree of cuticular sclerotization is an important 29 
factor in determining its physical properties. Spodoptera litura, the tobacco cutworm, is 30 
an important agricultural pest in Asia. Compared to the domestic silkworm, Bombyx 31 
mori, another lepidopteran whose CP genes have been well annotated, S. litura has a 32 
shorter life cycle, hides in soil during daytime beginning in the 5th instar and is exposed 33 
to soil in the pupal stage without the protection of a cocoon. In order to understand 34 
how the CP genes may have been adapted to support the characteristic life style of S. 35 
litura, we searched its genome and found 287 putative cuticular proteins that can be 36 
classified into 9 CP families (CPR with three groups (RR-1, RR-2, RR-3), CPAP1, 37 
CPAP3, CPF, CPFL, CPT, CPG, CPCFC and CPLCA), and a collection of unclassified 38 
CPs named CPH. There were also 112 cuticular proteins enriched in Histidine residues 39 
with content varying from 6% to 30%, comprising many more His-rich cuticular 40 
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proteins than B. mori. A phylogenetic analysis between S. litura, M. sexta and B. mori 41 
uncovered large expansions of RR-1 and RR-2 CPs, forming large gene clusters in 42 
different regions of S. litura chromosome 9. We used RNA-seq analysis to document 43 
the expression profiles of CPs in different developmental stages and tissues of S. litura. 44 
The comparative genomic analysis of CPs between S. litura and B. mori integrated 45 
with the unique behavior and life cycle of the two species offers new insights into their 46 
contrasting ecological adaptations. 47 
1. Introduction 48 
Insect cuticle must provide an effective barrier from the natural environment. 49 
Consequently, its physical properties, such as thickness, stiffness, strength, elasticity 50 
and color, show large variations at different metamorphic stages and in different 51 
anatomical regions. Cuticles have a common fundamental structure, consisting of a 52 
procuticle composed of a filamentous chitin structure within a protein matrix covered 53 
by an epicuticle consisting of lipids and protein above which there is a dense cuticulin 54 
lamina (Locke, 2001). The variation in physical properties of cuticle is partly due to 55 
different degrees of cross-linking and hardening occurring during the process of 56 
sclerotization, whereby phenolic material is incorporated into the CPs and/or other 57 
cross-links are formed. Additionally, numerous CPs are identified in all insect species 58 
studied, and their number and features are quite different among diverse species (Willis 59 
et al., 2012).  60 
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  Information about the CPs of various insects and their underlying genes has been 61 
obtained at the transcriptome and protein levels in the past few decades (Andersen, 62 
2000; Baton et al., 2009; Dittmer et al., 2015; Dong et al., 2016; Futahashi. et al., 2008; 63 
Gu and Willis, 2003; He et al., 2007; Pan et al., 2018). With the improvement of 64 
sequencing technology, more and more genomic information for insect CPs has 65 
become available, with many thousands of CP coding genes accumulated in sequence 66 
databases. Many CPs have been identified by their conserved protein sequence motifs. 67 
Andersen et al. (1995), Willis (2010) and Willis et al. (2012) have defined several CP 68 
families. The most abundant family of CPs contains the Rebers and Riddiford 69 
Consensus (R&R Consensus), which in an extended form has been shown to bind 70 
chitin (Dong et al., 2016; Rebers and Willis, 2001; Tang et al., 2010; Togawa et al., 71 
2007; Togawa et al., 2004). Three distinct forms of this consensus have been classified 72 
as RR-1, RR-2 and RR-3 (Andersen, 1998; Andersen, 2000). The other families with 73 
conserved motifs are CPs with a 44 amino acid motif (CPF), CPF-like in the conserved 74 
C-terminal region (CPFL), the Tweedle motif (CPT), alanine-rich CPs of low 75 
complexity (CPLCA), CPs of low complexity with two invariant glycine residues in 76 
the conserved domain (CPLCG), CPs of low complexity with an invariant tryptophan 77 
in the conserved domain (CPLCW), proline-rich CPs of low complexity (CPLCP), CPs 78 
with well-conserved cysteine residues (CPCFC), a glycine-rich CP (CPG), and analogs 79 
to peritrophins (CPAP1 and CPAP3). 80 
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  Spodoptera litura (Lepidoptera, Noctuidae) is an important agricultural pest 81 
distributed in the tropical and subtropical areas of Asia. Compared with the domestic 82 
silkworm, Bombyx mori, S. litura has a shorter life cycle, although it has one more 83 
larval instar (Fig. 1). In S. litura, instars L2-L5 are shorter than L1, whereas in B. mori, 84 
larval stages following L1 take increasingly longer times. Moreover, from the 5th 85 
instar S. litura hides in the soil during the daytime, comes out from the soil in the 86 
evening to eat crops throughout the night and then goes back into the soil with 87 
daybreak. Further, instead of residing in a protective cocoon from pupation until adult 88 
eclosion like B. mori, S. litura stays in the soil from the wandering stage until the moth 89 
emerges. This exposure to soil requires CPs to form a more protective cuticle for 90 
protection against abrasion and fungal and bacterial infection compared with B. mori. It 91 
is also informative to compare S. litura with M. sexta, a close relative of B. mori that 92 
stays underground during pupal and pharate adult stages. 93 
  In this study, we annotated CP genes based on the recently published complete 94 
genome sequence of S. litura (Cheng et al., 2017). Combined with transcriptome 95 
analysis, we then estimated what different kinds of CPs contribute to different types of 96 
cuticles among various tissues and in different metamorphic stages. In addition, 97 
comparative genomics and phylogenetic analysis among Lepidoptera provided 98 
information on how CP genes evolved to adapt to the different ecological niches of 99 
each of these three species.   100 
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                                                                                                                                                                               101 
2. Materials and Methods 102 
2.1 Annotation of cuticular protein genes 103 
To predict putative CP genes of S. litura, reported sets of lepidopteran CPs were 104 
collected from KAIKObase (http://sgp.dna.affrc.go.jp/KAIKObase/) and the NCBI 105 
Reference Sequence database (https://www.ncbi.nlm.nih.gov/genbank/). CP genes 106 
were predicted for the S. litura genome assembly (Cheng et al., 2017) using 107 
TBLASTN (E-value <10-5) and BLASTP in the non- redundant GenBank database. 108 
Predicted CP genes were further examined by HMMER3 search (cutoff E-value = 109 
0.001) using the Pfam database to confirm conserved domains and subsequently 110 
classified into 9 families based on conserved motifs with the help of an online tool 111 
(http://bioinformatics.biol.uoa.gr/CutProtFam-Pred/) (Ioannidou et al., 2014). The 112 
annotation sequences were deposited at GenBank under BioProject accession 113 
PRJNA344815. 114 
2.2 Phylogenetic tree construction 115 
A total of 199 RR-1 and 361 RR-2 CDS sequences from S. litura, B. mori, and M. sexta 116 
were aligned using ClustalW in MEGA6 (Tamura et al., 2013). The tree was 117 
constructed using the Maximum Likelihood method based on the Jukes-Cantor model 118 
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(Jukes and cantor, 1969). A bootstrap consensus tree was inferred from 1000 replicates 119 
(Felsenstein, 1985). Adobe Illustrator CS6 was used for editing and drawing the trees. 120 
  For the CPFL family, 17 sequences from S. litura, B. mori, and M. sexta were used 121 
for phylogenetic tree construction. The sequences were aligned using the program 122 
ClustalW in MEGA6 (Tamura et al., 2013). Trees were constructed using the 123 
Neighbor-Joining method (Nei, 1987), and gaps were treated by pairwise deletion. 124 
2.3 Insect rearing, RNA library preparation, and RNA-Seq 125 
S. litura (Ishihara inbred strain) was reared on artificial diet at 25°C under a 12h light/ 126 
12h dark cycle as described previously (Cheng et al., 2017), and RNA-Seq libraries 127 
were prepared from different developmental stages. For 1st and 2nd instar larvae (L1D2 128 
and L2D2), RNA was extracted from the whole body of second-day larvae. For 3rd to 129 
5th (L3D2, L4D2 and L5D2) instar samples, RNA was derived from epidermis of 130 
second-day larvae. For the 6th instar and wandering stages (L6D2 and W), epidermal 131 
RNA samples were collected from second day larvae in the daytime sleeping (D) phase 132 
and nighttime feeding phase (N). Although other tissues were removed carefully with 133 
tweezers under a ZEISS Stemi 2000 microscope (ZEISS, Germany), small amounts of 134 
muscle, fat body or trachea might have contaminated the libraries. RNA samples from 135 
epidermis and wing were extracted separately from 2nd (P-2), 6th (P-6), 9th and 12th-day 136 
pupae (P-9 and P-12: pharate adults). RNA isolation, library construction, sequencing 137 
and analysis of transcripts were carried out as described in Cheng et al. (2017). The 138 
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RNA-seq data are deposited in the Sequence Read Archive database under SRA 139 
accession: PRJNA498147 (https://www.ncbi.nlm.nih.gov/sra/PRJNA498147). The 140 
Log2 (FPKM+0.01) (fragments per kilobase per million fragments mapped) value was 141 
used for making the heat maps.  142 
3. Results and Discussion 143 
3.1 Annotation of cuticular proteins 144 
As shown in Table 1, 287 putative CP coding genes (Supplementary Table 1) were 145 
predicted and classified into eight CP families: CPR subdivided into three groups, 146 
(RR-1, RR-2 and RR-3), Tweedle, CPF, CPFL, CPLCA, CPCFC, CPAP1, CPAP3 and 147 
Glycine-rich (CPG). In addition, a collection of unclassified CPs was named CPH 148 
following Futahashi et al. (2008).  149 
  Among the 3 R&R consensus groups used to subdivide the CPR family in S. litura, 150 
63 RR-1 protein genes and 129 RR-2 protein genes were identified with 151 
CutProtFam-Pred, and one RR-3 protein gene was identified by manual annotation 152 
based on its similarity to RR-3 proteins in B. mori.  153 
  CPAP1 and CPAP3 families, which contain one or three peritrophin A-type chitin- 154 
binding domains, are expressed only in cuticle-forming tissues (Jasrapuria et al., 2010). 155 
Thirteen CPAP1s and 9 CPAP3s were annotated in the S. litura genome (Table 1) 156 
(Tetreau et al., 2015). 157 
 9 
  The CPLCA family is defined by the presence of the retinin domain (pfam04527) 158 
and richness in alanine residues, varying from 13-26% (Cornman and Willis, 2009). 159 
Four CPLCA genes (Sl_Aki-270, 271, 272 and 273) which formed a gene cluster in S. 160 
litura chromosome 28 (Chr28) were annotated. Two CPs, named BmorCPH6 and 161 
BmorCPH7 by Futahashi et al. (2008) in B. mori, were related to CPLCA by homology 162 
search. This is the first time CPLCAs, originally described in Anopheles gambiae 163 
(Cornman and Willis, 2009; Willis et al., 2012), were found in Lepidoptera.  164 
  CPF has a conserved region with 44 amino acids (Togawa et al., 2007). One putative 165 
CP gene belonging to the CPF family in the S. litura genome (SWUSl0111680) was 166 
identified which we named Sl_Aki-CPF. Seven CPFL genes, which have a conserved 167 
C-terminal region similar to CPF (Togawa et al., 2007), were found. All of the CPFL 168 
genes together with two other CPG genes (Sl_Aki-235 and 242) formed a cluster on 169 
Chr25. This genomic structure was similar to B. mori, in which three CPFL genes 170 
(BmorCPFL2, BmorCPFL3 and BmorCPFL4) and two CPG genes (BmorCPG23 and 171 
BmorCPG42) form a gene cluster on Chr23. In addition, Sl_Aki-235 and Sl_Aki-242 172 
were orthologous to BmorCPG23 and BmorCPG42, respectively. 173 
  We identified five genes with a Tweedle motif, among which Sl_Aki-292, 293 and 174 
294 formed a cluster on ChrZ; the other two CPT genes were not linked to other CPs. 175 
  The CPG family contains GG repeats but does not have any definite motif described 176 
in other CP families (Futahashi. et al., 2008; Willis et al., 2012). However, although 177 
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some glycine-rich cuticular proteins also had an R&R Consensus or Tweedle motif 178 
(i.e., Sl_Aki-008 (RR-1), Sl_Aki-185 (RR-2), and Sl_Aki-34 (CPT)), we left them in 179 
their well defined families. In S. litura, 28 putative CP genes were classified as CPGs. 180 
  Futahashi et al. (2008) classified a group of 34 proteins as CPH which stands for 181 
cuticular protein, hypothetical, among which we assigned BmorCPH6 and 7 to CPLCA 182 
and BmorCPH1 to CPCFC. They all have signal peptides and some sequence similarity 183 
with known CP genes or with the AAP (A/V) motif often found in CPs (Futahashi. et 184 
al., 2008; Magkrioti et al., 2004). Twenty-six putative CP genes which showed 185 
sequence similarity with 31 already known CPH proteins in B. mori were classified as 186 
CPH in S. litura. Most of them had signal peptides; additionally, the AAP (A/V) motif 187 
was found in 20 CPH proteins. Only 6 of these had sequence similarity with already 188 
known CPH proteins in B. mori. 189 
3.2 Characterization of histidine–rich CPs 190 
The amino acid composition of the 287 CPs revealed 112 His-rich CPs in which 191 
histidine residues ranged from 6.00–30.14% (Fig. 2). Interestingly, most His-rich CPs 192 
belonged to the RR-2 family, which is common to both B. mori and S. litura. B. mori 193 
has one extremely high His-rich CP, BmorCPR152, of 45%, while the orthologous CP 194 
with the highest His content in S. litura is Sl_Aki-166 with 30.14%. Figure 3 shows a 195 
large expansion of His-rich CPs of the RR-2 family in the S. litura genome. As 196 
Andersen and Roepstorff (2007) stated, histidine and several other amino acid residues 197 
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in CPs could be involved in cuticular adduct formation based on biochemical analysis 198 
of the cuticular hydrolysates from different cuticular types of M. sexta, desert locust 199 
Schistocerca gregaria, and yellow mealworm, Tenebrio molitor (Andersen, 2007; 200 
Andersen and Roepstorff, 2007; James L.Kerwin, 1999; Kerwin, 1999; SO Andersen 201 
1997). EM immunolocalization utilized by Vannini and Willis (2017) support the 202 
hypothesis about the deployment of RR-1 and RR-2 localization first proposed by 203 
Andersen (1998). Namely, the RR-1 CPs are mostly found in soft cuticle like 204 
inter-segmental membranes, whereas RR-2s are restricted to hard cuticles in A. 205 
gambiae (Vannini and Willis, 2017). Histidino-β-dopamine is the dominating adduct in 206 
hard cuticles like those of adult beetle cuticle, lepidopteran pupae and dipteran puparia 207 
(Andersen, 2008). Consistent with these reports is that His-rich CPs were mostly found 208 
in RR-2, but not RR-1 CPs of S. litura. 209 
3.3 Major clusters of CPR genes in S. litura 210 
Compared to B. mori which has a cluster of CPR genes on chromosome 22, major 211 
expansions of S. litura CPR genes derived from this family were on S. litura Chr9. 212 
Figure 3 shows that 34 RR-1 (Sl-Aki-48 - 80) genes and 82 RR-2 (Sl-Aki-86, 88 -94, 213 
96-169) genes were present as two large clusters located on different regions of Chr9. 214 
Intriguingly, all of the RR-2 CP members belonged to the cluster encoding His-rich 215 
CPs, whereas none of the 34 RR-1 CPs in the large cluster on Chr9 were His-rich. 216 
Chr22 in B. mori also has the orthologs of these RR-1 genes, but none of them were 217 
found to be His-rich (Fig. 3). Although much smaller than S. litura, there was a 218 
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separate His-rich RR-2 CP cluster (BmorCPR79-129) on Chr22 in B. mori. Thirteen 219 
RR-1 (Sl-Aki-001 - 013) genes were also localized on S. litura Chr1 as a cluster 220 
(Supplementary Fig. 1). Their orthologs in B. mori also formed a cluster on Chr9.  221 
3.4 Phylogenetic analysis of S. litura, B. mori and M. sexta CPs 222 
To compare the S. litura CPs with B. mori and M. sexta CPs, phylogenetic trees of 223 
RR-1 and RR-2 CPs were constructed separately (Fig. 4). A single species clade was 224 
very rare in the RR-1 tree. Although a small number of RR-1 CP genes were expanded 225 
in comparison with B. mori, more than half of them showed one-to-one correspondence 226 
among the three lepidopteran species. Sl_Aki-2, 3, 4, 5 and 6 and MsCPR13, 174, 175, 227 
176 and 177 formed separate clades, which corresponded to BmorCPR13 (black star in 228 
Fig. 4A). Another small species-specific RR-1 CP clade was observed (thick bar in Fig. 229 
4A). 230 
  In sharp contrast to the situation with RR-1s, more than half of the RR-2 CPs formed 231 
species-specific clades (Fig. 4B), indicating species-specific expansions by gene 232 
duplication events. Intriguingly, all CP members of S. litura, M. sexta and B. mori 233 
belonging to large species specific clades (green branch in Fig. 4B) were His-rich. 234 
Twenty-five RR-2 CPs (Sl_Aki-100-108, Sl_Aki-110-117, Sl_Aki-122, 124, 127, 129, 235 
132, 134 136) formed the biggest S. litura specific clade (Blue star in Fig.4B), all of 236 
which belonged to the RR-2 CP gene cluster in chr9. BmorCPR152, MsCPR152, 237 
MsCPR153 and Sl_Aki-166, which had the highest His-residue content in each species, 238 
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made a single clade (red star in Fig.4B), indicating that this highest His CP is 239 
conserved and may play a common role in some specific structure among the three 240 
Lepidoptera. Five of the CPFLs (Sl_Aki-236, 237, 238, 239, 240) formed a clade in S. 241 
litura (Supplementary Fig. 2).  242 
3.5 Transcript abundance of CPs  243 
We conducted RNA-Seq analysis to study the transcript distribution of CP genes in 244 
various developmental stages and tissues. In total, transcriptional evidence was 245 
obtained for 283 of the 287 annotated CPs (see Supplementary Table 2 for numbers of 246 
genes from each CP group expressed per library). Transcripts were found for a 247 
maximum of 233 CP genes in the 2nd instar larvae and a minimum of 94 CP genes in 248 
the epidermis of the 6th day pupa (Fig. 5A). The pattern of transcript levels of different 249 
CP groups (Fig. 5B) showed dynamic changes in epidermis from larval to pupal stages 250 
(Supplementary Table 3 for the total FPKM value for CP groups in each library). The 251 
transcript pattern of RR-1 CPs contrasted extremely compared to RR-2 CPs (Fig. 5B). 252 
Most CP transcripts in larval epidermis were derived from RR-1 CP genes whereas 253 
RR-2 transcripts predominated in pharate adults. The difference in transcript pattern 254 
between RR-1 and RR-2 genes was consistent with published reports that the RR-1 255 
transcripts are much more abundant in soft and flexible cuticles typical of larvae than 256 
in hard cuticles, whereas RR-2 transcripts are associated with hard structures typical of 257 
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adults (Dittmer et al., 2015; Ettershank, 1964 ; Futahashi. et al., 2008; Vannini and 258 
Willis, 2017).  259 
  The transcripts of CPG and CPH amount to a large percentage in pupal and pharate 260 
adult stages, despite their small numbers of genes compared with the CPR family 261 
(CPG 16-22; CPH 10-21; CPR 38-151) (Fig. 5A,B). In B. mori, transcripts from CPG 262 
genes are also reported to be present in some hard cuticles such as pheromone gland, 263 
compound eye and maxillary galea (Futahashi. et al., 2008). Most CPHs contain AAP 264 
(A/V) repeats which might cause a protein to fold into a more or less regular helix, 265 
leading to an elastin-like structure which is easily and reversibly deformed by external 266 
forces (Andersen, 1995). Transcripts of CPH genes were abundant in pupal epidermis 267 
and wing, especially in early pupal epidermis (Fig. 5B). Further study is needed to 268 
determine the function of the CPGs and CPHs in cuticle formation. 269 
  Wolfgang and Riddiford (1986) reported changes of CP synthesis correlated with 270 
changes of lamellar structure in M. sexta cuticle during the final larval instar when they 271 
dig into soil in preparation for pupation. Our RNA-Seq analysis of S. litura suggested 272 
that epidermal cuticular layers of 6th larval instar would be mainly composed of RR-1s 273 
as well as CPAPs, whereas, based on transcript abundance, CPH and CPGs together 274 
with CPAPs would contribute to the cuticular layers of the wandering stage (Fig. 5A; 275 
Fig. 6). Especially, CPHs encoded by Sl_Aki-260 (Supplementary Fig. 4) and Sl_Aki- 276 
261 (Supplementary Fig. 5) were extremely highly expressed in the wandering stage at 277 
night compared to the daytime. Nevertheless, the ratios of expressed gene numbers 278 
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among CP gene families did not change so much in epidermis between 6th larval instar 279 
and wandering stage (Fig. 5B). 280 
  The heat map of transcripts for each CP gene in S. litura showed several 281 
characteristic patterns (Fig. 6). The transcripts from RR-1 and CPG genes were 282 
continuously and highly abundant in epidermis of larval stages (Fig. 6A). However, 283 
transcripts from some RR-1 genes (Fig. 6B) that were abundant in larval epidermis 284 
were also found in the early pupal stage (P-2) or pharate adult stage (P-12). This is 285 
similar to An. gambiae, where Willis (2010) reported that both RR-1 and RR-2 286 
transcripts are present in pharate adults and post-eclosion, but many fewer are RR-1 287 
compared with RR-2.  288 
  The secondary structure predicted by online software Phyre2 (Kelley et al., 2015)  289 
(http://www.sbg.bio.ic.ac.uk/) for RR-1 CPs of pattern B (Fig. 6B) suggested that most 290 
of them shared a common structure homologous to the Polo-Box domain (Park et al., 291 
2010), which comprises a six-stranded antiparallel β-sheet shielded by one α-helix. 292 
However, we could not find such a common domain in RR-1 CPs of pattern A (Fig. 293 
6A). As Vannini and Willis (2017) reported, the location of RR-1s and RR-2s depends 294 
on properties of individual proteins in An. gambiae. It will be interesting to learn how 295 
RR-1s are involved in specific protein structures of adult cuticle. 296 
  The CPH genes (Sl_Aki-262, 265, 266, 267and 268) which formed a cluster on 297 
Chr28 and a small cluster of RR-2 genes (Sl_Aki-186, 187, 188, 189 and 190) in Chr15 298 
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(Supplementary table. 1) had transcripts mainly in late larval and early pupal stages 299 
(Fig. 6C).  300 
  RR-2 genes, which are the main members of “pattern D” of the heat-map (Fig. 6D), 301 
were highly expressed in the pharate adult wing and epidermis (P-9 and P-12). These 302 
genes were also well conserved among the three moth species with one-to-one 303 
correspondence in the phylogenetic trees (Fig. 4B). Sl_Aki-166, encoding the highest 304 
His-rich CP, had abundant transcripts in the pharate adult stage. This expression 305 
pattern was similar to its B. mori ortholog, BmorCPR152, which encodes the highest 306 
His-rich CP (Suetsugu et al., 2013). These CP genes, which were mainly expressed in 307 
the pharate adult stage, may contribute to scales or other specific structures in the adult. 308 
Not only RR-2 transcripts, but also transcripts from other CP families such as RR-1, 309 
CPG, CPFL, CPAP and CPH, were also observed in high abundance in pupal wing and 310 
epidermis (Fig. 6C, D). The finding that two RR-1 genes (Sl_Aki-182 and 210) were 311 
expressed highly only in the pupal stage, but not in the larval stage (Fig. 6D), is 312 
interesting since most RR-1 genes had high transcript levels in larval epidermis. The 313 
contrasting expression patterns of the genes encoding these two RR-1 proteins suggests 314 
that their function merits further study. 315 
  Transcripts from a few CPAP, RR-1 and CPH genes were observed in abundance in 316 
epidermis throughout the development and wing of pharate adult (Fig. 6E). The 317 
transcripts of three CPAP genes (Sl_Aki-20, 22 and 23) showed a steady high 318 
abundance in epidermis in all stages of pupal wing. These three genes are orthologs of 319 
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CPAP3-A1, CPAP3-B and CPA3-C in both M. sexta and T. castaneum. Their 320 
biological importance is indicated by reports that RNAi knockdown of TcCPAP3-A1 321 
causes adult lethality, down-regulation of the TcCPAP3-B causes a walking defect and 322 
RNAi treatment for TcCPAP3-C leads to molting arrest at the pharate adult stage 323 
(Jasrapuria et al., 2012; Petkau et al., 2012).  324 
  His-rich RR-2 genes (Sl_Aki-100-108, Sl_Aki-110-117, Sl_Aki-122, 124, 127, 129, 325 
132, 134 136), which form the large species-specific clade in the phylogenetic tree 326 
(Blue star in Fig.4B), unexpectedly showed few transcripts in epidermis or other 327 
samples (Supplementary Fig. 3). However, since the transcripts were only examined in 328 
limited tissues in this study, we estimate these species-specific His-rich CP genes may 329 
be expressed in some hard cuticle structures such as the cornea of the compound eye, 330 
maxilla, or antenna. 331 
  Another unexpected finding was that transcripts from CPG, CPAP, CPT, CPH, 332 
RR-1and RR-2 were present in relatively high abundance at the 2nd instar 333 
(Supplementary Fig. 4), which was quite different from those of other larval stages. 334 
Other CPs that were abundant at later stages also had high levels of transcripts in the 335 
2nd instar (Supplementary Fig. 5). Among several possibilities to explain this peculiar 336 
expression pattern across all the samples is the large/major morphological change that 337 
occurs in larvae during the transition from 1st to 2nd instar. Further study of the 338 
ultrastructure and physical properties of larval cuticle at these stages may help to 339 
explain this observation. Another likely possibility is related to the timing of sample 340 
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collection. If the sampling was performed at the pharate third instar stage, CP 341 
expression would be higher than in mid-instar larvae. It is also of interest to check the 342 
transcripts of CP genes in the pharate stage. Levels of other CP transcripts are shown 343 
in Supplementary Figure 5. 344 
4. Conclusion 345 
S. litura, among the most economically important global agricultural pests, is 346 
characterized by a short life cycle, direct contact with soil during both late larval and 347 
pupal/pharate adult stages, long distance migration and quick adaptation to diverse 348 
ecological niches. RNA-Seq analysis suggests that differential expression of various 349 
CP groups to produce cuticle layers with different physical properties at different 350 
stages. This study aimed to illustrate how the CP genes have been adapted to the 351 
characteristic life style of this pest by analyses of their genome organization, 352 
phylogenetics and transcriptomics. Similar to M. sexta (Dittmer et al., 2015), the RR-2 353 
group has expanded more than other CP groups, largely by gene duplication events 354 
after speciation. Additionally, we found that 91 of 129 RR-2 CPs are His-rich, 355 
amounting to twice the number and a greater fraction than in B. mori (from 58% in B. 356 
mori to 71% in S. litura). These His-rich proteins are likely involved in cuticular 357 
sclerotization since a His residue, which contains a nucleophilic imidazole group, can 358 
react with ortho-quinone or dehydrobenzodioxine (Andersen, 2010, 2012). Although 359 
more evidence is needed, we speculate that the high content of His-residues and the 360 
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large expansion of His-rich RR-2 CP genes that occur in S. litura could contribute to 361 
construct tougher cuticles that could protect against fungal and bacterial attacks and 362 
abrasion throughout their larval and pupal stages. Comparison with M. sexta CPs also 363 
strengthened this idea, since both species which stay under soil during pupal/pharate 364 
adult stages without cocoons share D large expansion of His-rich RR-2 CP genes 365 
compared with B. mori.  366 
  The present work clearly showed how this pest established its unique life cycle 367 
through the expansion of His-rich CP genes, which provides insights into the possible 368 
regulation of CPs for pest control and their properties as new biomaterials. 369 
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Figure Captions 502 
Figure 1. Differences in behavior and life cycle between S. litura and B. mori. L1-L6 503 
refer to larval instars 1-6; W is the wandering stage; numbers in parentheses represent 504 
days at a particular stage.  505 
Figure 2. The number of His-rich CPs in each CP group. His-rich RR-2 CPs in S. litura, 506 
91; B. mori, 54; His-rich RR-1 CPs in S. litura, 0; B. mori: 2; His-rich CPGs in S. litura, 507 
11; B. mori 9; His-rich CPLCA in S. litura, 3; B. mori, 1; His-rich CPAP in S. litura, 3; 508 
B. mori, 1; His-rich CPH in S. litura, 4; B. mori, 2. Blue, B. mori CPs; red, S. litura 509 
CPs. 510 
Figure 3. Chromosomal location of the largest cluster of CPR genes in S. litura 511 
compared with B. mori. RR-1 genes (red) and RR-2 genes (blue) are located primarily 512 
in separate clusters on chromosome 9. Arrows indicate direction of transcription.   513 
Figure 4. Phylogenetic trees of annotated RR-1 and RR-2 proteins among S. litura, B. 514 
mori and M. sexta. (A) RR-1 protein genes. Black star, BmorCPR13; thick bar, 515 
species-specific clade. (B) RR-2 protein genes. blue, M. sexta CPs; yellow, B. mori 516 
CPs; magenta, S. litura CPs; blue star, 25 RR-2 CPs forming the biggest S. litura 517 
specific clade; red star, highest His-content RR-2 CP among the three species, forming 518 
 27 
a clade. Green branch, His-rich CP genes. Bootstrap values of 70 or higher are shown 519 
in the branches.  520 
Figure 5. Transcript distribution of CP genes in RNA-Seq libraries. (A) Total FPKM 521 
values of transcripts for CP genes in each family. (B) Numbers of CP genes with 522 
transcripts in each family. EP, Epidermis; D, daytime; N, nighttime; Wg, wing.  523 
Figure 6. Heatmap of transcripts of S. litura CP genes grouped into five distinct 524 
patterns. (A) CP transcripts mainly found in the larval epidermis. (B) CP transcripts 525 
expressed highly in larval and pharate adult stages. (C) CP transcripts expressed highly 526 
in epidermis of late larval to early pupal stages. (D) CP transcripts found mainly in the 527 
pharate adult stage. (E) Transcripts of CP genes highly abundant through the larval to 528 
pupal stage.  529 
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Table1. Size of each cuticular protein family in Spodoptera litura and Bombyx mori
 a, b, c items in parentheses refer to CPs reported in Futahashi et al. (2008) 










SWUSl #(New) Chr Start (chr) End (chr) dir scaffold Start (scaf) End (scaf) dir CDS (bp) aa length exon # protein feature
Sl_Aki-001 RR-1 15 SWUSl10006476 SWUSl0006070 1 mRNA 1908343 1909789 + scaffold227 377929 376483 - 1005 335 2 Gly54(16.2%),Ala46(13.77%),Ser39(11.7%),Pro33(9.9%)
Sl_Aki-002 RR-1 15 SWUSl10006475 SWUSl0006080 1 mRNA 1926011 1927618 + scaffold227 360261 358654 - 1116 371 4 Gln31(8.4%),Ala59(15.9%),Ser40(10.8%),Asn52(14.0%)
Sl_Aki-003 RR-1 15 SWUSl10006474 SWUSl0006090 1 mRNA 1930513 1931607 + scaffold227 355759 354665 - 846 281 4 Ala44(15.7%),Ser30(10.7%),Gln24(8.5%)；Gly(G)23(8.19%)；Gln(Q)24(8.54%)
Sl_Aki-004 RR-1 15 SWUSl10006473 SWUSl0006100 1 mRNA 1935412 1936440 + scaffold227 350860 349832 - 693 230 4 Ala36(15.7%),Ser24(10.4%)；Gly(G)22(9.57%)
Sl_Aki-005 RR-1 15 SWUSl10006472 SWUSl0006110 1 mRNA 1942925 1943888 - scaffold227 342384 343347 + 690 229 4 Ala40(17.5%),Ser21(9.1%)；Gly(G)22(9.61%)
Sl_Aki-006 RR-1 15 SWUSl10006471 SWUSl0006120 1 mRNA 1947817 1948628 - scaffold227 337644 338455 + 564 187 3 Ala29(15.5%),Gly(G)18(9.63%)；Ser16(8.6%),Gln15(8.0%),Glu13(7.0%)
Sl_Aki-007 RR-1 0 1SWUSl10006470 SWUSl0006130 1 mRNA 1956832 1957664 + scaffold227 329440 328608 - 600 199 2 Ser21(10.6%), Pro(P17(8.54%)；Gly(G)18(9.05%) ；Asn14(7.0%),Asp13(6.5%),Glu12(6.0%)
Sl_Aki-008 RR-1 15 SWUSl10006469 SWUSl0006140 1 mRNA 2026662 2027410 + scaffold227 259610 258862 - 702 232 2 Gly62(26.7%),Ala38(16.4%)
Sl_Aki-009 RR-1 15 SWUSl10006465 SWUSl0006180 1 mRNA 2067075 2069668 + scaffold227 219197 216604 - 591 196 4 Gly35(17.9%),Gln18(9.2%),Glu12(6.1%)；Ala(A)16(8.16%)  
Sl_Aki-010 RR-1 17 SWUSl10006464 SWUSl0006190 1 mRNA 2073274 2081041 - scaffold227 205231 212998 + 522 173 4 Gly18(10.4%),Ala29(16.8%),Gln17(9.8%),Glu13(7.5%)
Sl_Aki-011 RR-1 17 SWUSl10006463 SWUSl10006463 1 mRNA 2100870 2102356 - scaffold227 183916 185402 + 558 185 3 Ala25(13.5%),Glu19(10.3%)；Gly(G)16(8.65%)；Ser(S)16(8.65%)
Sl_Aki-012 RR-1 15 SWUSl10006462 SWUSl0006210 1 mRNA 2114423 2118483 - scaffold227 167789 171849 + 531 176 4 Ala28(15.9%),Tyr20(11.4%)
Sl_Aki-013 RR-1 17 SWUSl10006461 SWUSl0006220 1 mRNA 2183105 2188858 + scaffold227 103167 97414 - 522 173 4 Gly20(11.6%),Ala21(12.1%),Ser17(9.8%),Tyr16(9.3%)
Sl_Aki-014 His:6.34% RR-2 16 SWUSl10008742 SWUSl0006900 1 mRNA 3888642 3889806 + scaffold148 329196 330360 + 1014 337 3 Gly58(17.2%),Ala44(13.1%),Leu38(11.3%),Pro42(12.5%),Tyr23(6.8%);His(H)13(6.34%)
Sl_Aki-015 RR-2 0 none 1 mRNA 3892472 3893190 + scaffold148 333026 333744 + 567 188 2 Val(V)20(10.64%);Pro(P)20(10.64%);Leu(L17(9.04%);Gly(G)16(8.51%) 
Sl_Aki-016 RR-2 17 SWUSl10008743 SWUSl0006910 1 mRNA 3896561 3897515 + scaffold148 337115 338069 + 729 242 3 Pro(P)37(15.29%);Ile(I)30(12.40%);Ala(A)26(10.74%);Val(V) 22(9.09%);Gly(G) 20( 8.26%)
Sl_Aki-017 CPAP1-O 16 10008760 SWUSl0007070 1 mRNA 4374169 4401774 + scaffold148 814723 842328 + 2178 725 5 CBM_14 [58-113]; ChtBD2 [56-107]
Sl_Aki-018 CPG 18 SWUSl10002513 SWUSl0007210 1 mRNA 4651364 4652844 - scaffold475 26962 25482 - 867 288 3 Ala(A)98(34.03%);Gly(G)38(13.19%); Val(V)24(8.33%)
Sl_Aki-019 CPG 18 SWUSl10002514 SWUSl0007220 1 mRNA 4657887 4659053 - scaffold475 33171 32005 - 957 318 3 Ala(A)100(31.45%);Gly(G)62(19.50%);
Sl_Aki-020 CPAP3-A1 16 10014992 SWUSl0011690 2 mRNA 2527417 2538168 + scaffold19 563624 574375 + 714 237 5 CBM_14 [20-72][90-136][174-219]; ChtBD2 [15-68][89-135][174-213]
Sl_Aki-021 CPAP3-A2 17 10014993 SWUSl0011700 2 mRNA 2554095 2573487 + scaffold19 590302 609694 + 717 238 7 CBM_14 [22-74][92-140][175-221]; ChtBD2 [20-68][91-117][176-215[
Sl_Aki-022 CPAP3-B 20 10014995 SWUSl0011720 2 mRNA 2614697 2626168 - scaffold19 650904 662375 - 897 298 6 CBM_14 [57-107][124-174][201-246]; ChtBD2 [53-102][121-169][185-240[
Sl_Aki-023 CPAP3-C 0 10014997 SWUSl0011740 2 mRNA 2651114 2655006 - scaffold19 687321 691213 - 756 251 5 CBM_14 [14-67][99-135][161-209]
Sl_Aki-024 CPAP3-D1 19 10014994 SWUSl0011710 2 mRNA 2584663 2612712 + scaffold19 620870 648919 + 687 228 5 CBM_14 [37-84][104-146][161-225]; ChtBD2 [27-67][100-145][160-210]
Sl_Aki-025 CPAP3-D2 0 10015026 SWUSl0012000 2 mRNA 3508533 3590600 + scaffold19 1544740 1626807 + 870 289 7 CBM_14 [74-122][143-183][195-241]; ChtBD2 [73-102][142-183][193
Sl_Aki-026 CPAP3-E1 17 10004597 SWUSl0012480 2 mRNA 4756976 4767956 - scaffold317 4557 15537 - 873 290 6 CBM_14 [65-111][65-180][207-252]; ChtBD2 [64-103][131-174][207-244]
Sl_Aki-027 CPAP3-E2 20 10004596 SWUSl0012470 2 mRNA 4754218 4756301 - scaffold317 1799 3882 - 690 229 6 CBM_14 [105-154]; ChtBD2 [29-71][99-148]
Sl_Aki-028 His:7.2% CPG 20 SWUSl10007758 SWUSl0023630 5 mRNA 6253148 6254637 - scaffold179 213819 212330 - 1272 423 2 Gly47(11.1%),Val75(17.7%),pro54(12.8%),Lys54(12.8%)
Sl_Aki-029 His:12.08% RR-2 20 SWUSl10004457 SWUSl0024960 5 mRNA 11008737 11010425 + scaffold333 123549 125237 + 510 169 4 Gly(G)16(9.47%);His(H)18(10.65%);Asp(D)16(9.47%);
Sl_Aki-030 RR-2 0 SWUSl10008705 SWUSl0028730 6 mRNA 8630640 8630997 - scaffold147 136204 136561 + 222 73 2 Gly10(13.7%),Glu8(11.0%)
Sl_Aki-031 RR-1 19 SWUSl10006212 SWUSl0028900 6 mRNA 9206793 9208785 - scaffold240 163876 165868 + 426 141 4 Ala21(14.9%),Val16(11.4%);Pro(P)13(9.22%);
Sl_Aki-032 RR-1 18 SWUSl10006211 SWUSl0028910 6 mRNA 9222242 9226193 - scaffold240 146468 150419 + 429 142 4 Ala18(12.7%),Ser15(10.6%);Val(V)14(9.86%);Pro(P)14(9.86%)
Sl_Aki-033 RR-1 19 SWUSl10006210 SWUSl0028920 6 mRNA 9242940 9245784 - scaffold240 126877 129721 + 396 131 4 Ala18(13.7%),Ser11(8.4%);Pro(P)11(8.40%);Tyr10(7.6%);Val(V)11(8.40%)
Sl_Aki-034 CPT 0 none 6 mRNA 10461771 10462919 - scaffold37 597328 598476 + 891 296 2 Gly(G)113(38.18%);Ser(S)30(10.14%);Ile(I)26(8.78%);
Sl_Aki-035 RR-2 19 SWUSl10012478 SWUSl0031190 7 mRNA 4070112 4071480 + scaffold63 317084 318452 + 489 162 3 Pro(P)19(11.73%);Ala(A)18(11.11%);Gly(G)14(8.64%);Ser(S)13(8.02%)
Sl_Aki-036 RR-2 0 SWUSl10005425 SWUSl0034970 7 mRNA 14722300 14723922 + scaffold275 271283 269661 - 1236 411 2 Gln(Q)55(13.38%);Pro(P)52(12.65%);Ala(A) 41(9.98%)
Sl_Aki-037 CPH 0 SWUSl10005424 SWUSl0034980 7 mRNA 14732155 14734131 + scaffold275 261428 259452 - 1884 627 2 Pro60(9.6%);Gln(Q)49(7.81%);
Sl_Aki-038 RR-1 16 SWUSl10005423 SWUSl0034990 7 mRNA 14740689 14746822 - scaffold275 246761 252894 + 969 322 6 Pro54(16.8%),Gln41(12.7%);Ala(A)29(9.01%); 
Sl_Aki-039 RR-2 16 SWUSl10005421 SWUSl0035010 7 mRNA 14779444 14782211 - scaffold275 211372 214139 + 852 283 3 Pro35(12.4%),Gln48(17.0%),Ala(A)23(8.13%)
Sl_Aki-040 CPAP1-J 0 10005116 SWUSl0035530 8 mRNA 465865 479760 - scaffold290 7953 21848 + 3939 1312 5 CBM_14 [114-168]; ChtBD2 [112-160]
Sl_Aki-041 CPAP1-K 23 10008046 SWUSl0036010 8 mRNA 2308511 2376767 - scaffold168 750940 819196 - 2232 743 8 CBM_14 [377-436]; ChtBD2 [375-429]
Sl_Aki-042 RR-2 24 SWUSl10000941 SWUSl0037080 8 mRNA 6197309 6198596 + scaffold719 44772 46059 + 480 159 3 Ala29(18.2%),Val21(13.2%),Pro17(10.7%),Tyr12(7.6%);Gly(G)12(7.55%)
Sl_Aki-043 RR-2 16 SWUSl10000941 SWUSl0037080 8 mRNA 6203090 6203803 + scaffold719 50553 51266 + 489 162 3 Val19(11.7%),Pro17(10.5%),Tyr10(6.2%)
Sl_Aki-044 His:6.79% RR-2 17 SWUSl10000943 SWUSl0037100 8 mRNA 6209259 6209910 + scaffold719 56722 57373 + 540 179 2 Ala45(25.1%),Val33(18.4%),His11(6.2%),Tyr13(7.3%)Pro(P)15(8.38%)
Sl_Aki-045 CPAP1-L 16 10016513 SWUSl0037740 8 mRNA 8306915 8317130 + scaffold3a 2092833 2103048 + 969 322 2 CBM_14 [189-232]; ChtBD2 [189-229]
Sl_Aki-046 RR3 SWUSl10005702 SWUSl0039150 9 mRNA 35018 38125 + scaffold270 35018 38125 + 987 328 7 Ala(A)33(10.06%);Gln(Q)30(9.15%);Glu(E)27(8.23%)
Sl_Aki-047 His:6.82% CPG 21 SWUSl10006973 SWUSl0039470 9 mRNA 879767 881529 - scaffold205 629386 631148 + 330 109 2 Gly(G)21(19.27%);Tyr(Y)15(13.76%);Ala(A)12(11.01%);Leu(L)8(7.34%);
Sl_Aki-048 RR-1 17 SWUSl10010732 SWUSl0041300 9 mRNA 6326599 6327479 + scaffold99 625033 625913 + 342 113 3 Ala12(10.6%),Val14(12.4%),Glu14(12.4%);Gly(G) 11(9.73%); 
Sl_Aki-049 RR-1 17 SWUSl10010733 SWUSl0041310 9 mRNA 6332264 6332994 + scaffold99 630698 631428 + 339 112 3 Val17(15.2%),Glu11(9.8%);Ser(S)10(8.93%) ;
Sl_Aki-050 RR-1 18 SWUSl10010734 SWUSl0041320 9 mRNA 6336677 6337362 + scaffold99 635111 635796 + 339 112 3  Ile(I) 12(10.71%);Ala11(9.8%),Val11(9.8%),Glu11(9.8%),Asp8(7.1%),Ser10(8.9%)
Sl_Aki-051 RR-1 17 SWUSl10010735 SWUSl0041330 9 mRNA 6343990 6344643 + scaffold99 642424 643077 + 342 113 3 Val14(12.4%),Glu13(11.5%),Asp8(7.1%),Lys9(8.0%);Ala(A) 10( 8.85%)
Sl_Aki-052 RR-1 17 SWUSl10010736 SWUSl0041340 9 mRNA 6349952 6350485 + scaffold99 648386 648919 + 342 113 3 Asp9(8.0%),Glu9(8.0%),Lys8(7.1%)
Sl_Aki-053 RR-1 21 SWUSl10010737 SWUSl0041350 9 mRNA 6357430 6359574 + scaffold99 655864 658008 + 813 270 4 Pro(P)41(15.19%);Tyr(Y)24(8.89%);
Sl_Aki-054 RR-1 16 SWUSl10010738 SWUSl0041360 9 mRNA 6362254 6365344 + scaffold99 660688 663778 + 471 156 4 Pro17(10.9%),Gln26(16.7%)
Sl_Aki-055 RR-1 29 SWUSl10010739 SWUSl0041370 9 mRNA 6369614 6370305 + scaffold99 668048 668739 + 444 147 2 Ala(A)25(17.01%); Pro(P)14(9.52%) ;
Sl_Aki-056 RR-1 15 SWUSl10010740 SWUSl0041380 9 mRNA 6375964 6376538 + scaffold99 674398 674972 + 384 127 2 Ala17(13.4%),Pro14(11.0%),Glu12(9.5%),Gln10(7.9%)
Sl_Aki-057 RR-1 15 SWUSl10010741 SWUSl0041390 9 mRNA 6384086 6385488 + scaffold99 682520 683922 + 582 193 5 Ala(A)47(24.35%);Val(V)21(10.88%);Pro(P)17(8.81%)
Sl_Aki-058 RR-1 0 SWUSl10010742 SWUSl0041400 9 mRNA 6398507 6399233 + scaffold99 696941 697667 + 480 159 2 Gly32(20.1%),Ser24(15.1%)
Sl_Aki-059 CPG 16 SWUSl10010743 SWUSl0041410 9 mRNA 6404981 6407713 + scaffold99 703415 706147 + 825 274 3 Gly51(18.6%),Pr024(8.8%),Tyr30(11.0%)
Sl_Aki-060 RR-1 0 SWUSl10010744 SWUSl0041420 9 mRNA 6414609 6415382 + scaffold99 713043 713816 + 372 123 2 Ala14(11.4%),Tyr11(8.9%);Val(V)12( 9.76%);
Sl_Aki-061 RR-1 16 SWUSl10010745 SWUSl0041430 9 mRNA 6417948 6418940 + scaffold99 716382 717374 + 447 148 4 Ala23(15.5%),Pro18(10.1%)
Sl_Aki-062 RR-1 16 SWUSl10010746 SWUSl0041440 9 mRNA 6424026 6424882 + scaffold99 722460 723316 + 552 133 4 Ala24(13.1%),Pro26(14.2%),Tyr13(7.1%);Val(V) 18(9.84%);
Sl_Aki-063 RR-1 0 SWUSl10010747 SWUSl0041450 9 mRNA 6456133 6458055 + scaffold99 754567 756489 + 306 101 3 Ala13(12.9%),Pro14(13.9%);Gly(G)9(8.91%)
Sl_Aki-064 RR-1 0 SWUSl10010748 SWUSl0041460 9 mRNA 6461526 6463766 - scaffold99 762200 759960 - 762 253 3 Thr23(9.1%),Glu22(8.7%),Lys21(8.3%),Arg21(8.3%)
Sl_Aki-065 RR-1 16 SWUSl10010750 SWUSl0041480 9 mRNA 6482122 6483444 + scaffold99 780556 781878 + 585 194 3 Pro16(8.3%),Gln19(9.8%)
Sl_Aki-066 RR-1 0 SWUSl10010751 SWUSl0041490 9 mRNA 6497412 6501292 + scaffold99 795846 799726 + 330 109 3 Gly11(10.1%),Ala12(11.0%),Pro13(11.9%),Glu10(9.2%)
Sl_Aki-067 RR-1 17 SWUSl10010752 SWUSl0041500 9 mRNA 6516199 6520405 + scaffold99 814633 818839 + 465 154 4 Ala17(11.0%),Gln30(19.5%);Gly(G)13(8.44%) 
Sl_Aki-068 RR-1 25 SWUSl10010753 SWUSl0041510 9 mRNA 6525848 6526709 + scaffold99 824282 825143 + 360 119 3 Val13(10.9%),Asp12(10.1%),Asn9(7.6%);Ala(A)11(9.24%)
Sl_Aki-069 RR-1 25 SWUSl10010754 SWUSl0041520 9 mRNA 6529555 6532078 + scaffold99 827989 830512 + 351 116 3 Ala(12.9%),Asn11(9.5%),Asp6(5.2%),Glu9(7.8%);Asn(N)11(9.48%);Gly(G)10(8.62%)
Sl_Aki-070 RR-1 25 SWUSl10010755 SWUSl0041530 9 mRNA 6534162 6534832 + scaffold99 832596 833266 + 351 116 3 Val12(10.3%),Asn12(10.3%),Asp7(6.0%),Glu7(6.0%),Gln8(6.9%);
Sl_Aki-071 RR-1 0 SWUSl10010756 SWUSl0041540 9 mRNA 6553707 6554162 + scaffold99 852141 852596 + 342 113 2 Arg13(11.5%),Asp7(6.2%);Gly(G)11(9.73%);
Sl_Aki-072 RR-1 15 SWUSl10010757 SWUSl0041550 9 mRNA 6565425 6565935 + scaffold99 863859 864369 + 351 116 3 Gly12(10.3%),Ala15(12.9%),Val12(10.3%),Gln13(11.2%)
Sl_Aki-073 RR-1 15 SWUSl10010758 SWUSl0041560 9 mRNA 6570665 6571655 + scaffold99 869099 870089 + 363 120 3 Gly13(10.0%),Ala15(12.5%),Val14(11.7%),Asp9(7.5%),Asn7(5.8%),Glu7(5.8%);acidic
Sl_Aki-074 RR-1 15 SWUSl10010759 SWUSl0041570 9 mRNA 6574976 6575744 + scaffold99 873410 874178 + 363 120 3 Gly13(10.8%),Ala14(11.7%),Val15(12.5%),Asp9(7.5%),Asn7(5.8%)
Sl_Aki-075 RR-1 15 SWUSl10010760 SWUSl0041580 9 mRNA 6578924 6579679 + scaffold99 877358 878113 + 357 118 3 Gly16(13.6%),Ala12(10.2%),Val14(11.9%)
Sl_Aki-076 RR-1 15 SWUSl10010761 SWUSl0041590 9 mRNA 6587290 6588020 + scaffold99 885724 886454 + 348 115 3 Gly14(12.2%),Ala12(10.4%),Val15(13.0%),Asn8(7.0%),Asp7(6.1%),Glu7(6.1%)
Sl_Aki-077 RR-1 17 SWUSl10010763 SWUSl0041610 9 mRNA 6598391 6608913 + scaffold99 896825 907347 + 321 106 3 Ala(A)11(10.38%)；Gly(G)9(8.49%)；
Sl_Aki-078 RR-1 17 SWUSl10010764 SWUSl0041620 9 mRNA 6610771 6611988 + scaffold99 909205 910422 + 312 103 3 Val(V)9(8.74%)
Sl_Aki-079 RR-1 17 SWUSl10010765 SWUSl0041630 9 mRNA 6614940 6616458 - scaffold99 914892 913374 - 360 119 3 Ala23(19.3%),Asp9(7.6%),Glu9(7.6%),Gln9(7.6%);Val(V)11(9.24%)；acidic
Sl_Aki-080 RR-1 19 SWUSl10010767 SWUSl0041640 9 mRNA 6637363 6640548 + scaffold99 935797 938982 + 318 105 3 Val11(10.5%),Gln9(8.57%)；Ala(A)10(9.52%)；Gly(G)9(8.57%) 
Sl_Aki-081 RR-2 27 SWUSl10010768 SWUSl0041650 9 mRNA 6660539 6663448 + scaffold99 958973 961882 + 1605 534 4 Gly63(11.8%),Ser60(11.2%),Pro46(8.6%),Gln45(8.4%)
Sl_Aki-082 RR-2 17 SWUSl10010769 SWUSl0041660 9 mRNA 6678768 6709257 + scaffold99 977202 1007691 + 1062 353 4 Pro(P)34(9.63%);Ser(S)31(8.78%);Thr(T)30(8.50%);Tyr(Y)28(7.93%);Arg(R)26(7.37%);Asp(D)25(7.08%);Gly(G)25( 7.08%);Gln(Q)25(7.08%);
Sl_Aki-083 RR-2 25 SWUSl10008518 SWUSl0041940 9 mRNA 7119339 7121766 - scaffold154 596714 599141 + 1374 457 4 Pro(P)66(14.44%);
Sl_Aki-084 CPAP1-M 0 10008194 SWUSl0042310 9 mRNA 8290351 8294236 + scaffold163 421184 425069 - 2241 746 5 CBM_14 [59-117]; ChtBD2 [57-109]
Sl_Aki-086 RR-2 19 SWUSl10008112 SWUSl0042990 9 mRNA 9435634 9436149 + scaffold167 569866 568351 - 462 153 3 Ala(A)14(9.15%);Val(V)15(9.80%);Gly(G)13(8.50%);
Sl_Aki-088 RR-2 0 SWUSl10008109 SWUSl0043020 9 mRNA 9473801 9474790 + scaffold167 530699 529710 - 255 84 3 Val(V)9(10.71%);Asp(D)8(9.52%);Gly(G)7(8.33%);Ser(S)7(8.33%)
Sl_Aki-089 RR-2 19 SWUSl10008108 SWUSl0043030 9 mRNA 9483506 9486486 + scaffold167 520994 518014 - 492 163 4 Pro(P)18(11.04%);Tyr(Y)15(9.20%);Val(V)14(8.59%)
Sl_Aki-090 His:8.33% RR-2 0 SWUSl10008107 SWUSl0043040 9 mRNA 9502924 9504139 + scaffold167 501576 500361 - 327 108 3 Val(V)9(8.33%);His(H)9(8.33%)
Sl_Aki-091 RR-2 0 SWUSl10008107 SWUSl0043040 9 mRNA 9509153 9512544 + scaffold167 495347 491956 - 432 143 3 Pro16(11.89%),Tyr16(11.2%);Val(V)13(9.09%)
Sl_Aki-092 His:8.2% RR-2 0 SWUSl10008105 SWUSl0043060 9 mRNA 9655274 9656994 + scaffold167 349226 347506 - 441 146 4 Thr14(9.6%),His12(8.2%)
Sl_Aki-093 RR-2 0 SWUSl10008104 SWUSl0043070 9 mRNA 9664925 9666591 + scaffold167 339575 337909 - 1137 378 3 Asp(D)44(11.64%);Lys(K)38(10.05%);Pro(P)37(9.79%)
Sl_Aki-095 RR-2 17 SWUSl10008103 SWUSl0043080 9 mRNA 9683393 9684597 + scaffold167 321107 319903 - 360 119 3 Ala(A)20(16.81%);Gly(G)19(15.97%);Val(V)10(8.40%);Leu(L)9(7.56%)
Sl_Aki-096 His:20.27% RR-2 16 SWUSl10008102 SWUSl0043090 9 mRNA 9685974 9687179 + scaffold167 318526 317321 - 717 238 3 His(H)45(18.91%);Ala(A)23(9.66%);Glu(E)20(8.40%);Gly(G)19(7.98%);Ser(S)19(7.98%);Val(V)18(7.56%);Tyr(Y)17(7.14%)
Sl_Aki-097 His:20.0% RR-2 0 none 9 mRNA 9692646 9693858 - scaffold167 310642 311854 + 558 185 3 His-rich(20.0%);Ala(A)25(13.51%);Val(V)24(12.97%);Pro(P)15(8.11%)
Sl_Aki-098 His:15.43% RR-2 17 SWUSl10008100 SWUSl0043110 9 mRNA 9697929 9699559 - scaffold167 304941 306571 + 618 205 3 His(H)29(14.15%);Val(V)26(12.68%);Lys(K)20(9.76%);Ala(A)19(9.27%); Tyr(Y)15(7.32%);Glu(E)15(7.32%)
Sl_Aki-099 His:17.76% RR-2 17 none 9 mRNA 9701697 9702778 + scaffold167 302803 301722 - 375 124 3 Gly22(17.7%),His19(15.3%)
Sl_Aki-100 His:26.47% RR-2 16 none 9 mRNA 9707439 9808350 + scaffold167 297061 196150 - 663 220 3 Glu24(10.9%),His54(24.6%)
Sl_Aki-101 His:24.32% RR-2 16 none 9 mRNA 9712175 9713023 + scaffold167 292325 291477 - 606 201 3 Glu20(10.0%),His45(22.4%)
Sl_Aki-102 His:25.13% RR-2 17 none 9 mRNA 9715794 9717180 + scaffold167 288706 287320 - 615 204 3 His(H)47(23.04%);Glu(E)21(10.29%);Gln(Q)17(8.33%);
Sl_Aki-103 His:25.37% RR-2 16 none 9 mRNA 9721706 9722600 + scaffold167 282794 281900 - 654 217 3 Glu24(11.1%),His51(23.5%)
Sl_Aki-104 His:14.44% RR-2 16 none 9 mRNA 9726117 9726663 - scaffold167 277837 278383 + 321 106 3 Val12(11.3%),Lys11(10.4%),His13(12.3%)
Sl_Aki-105 His:24.71% RR-2 16 none 9 mRNA 9727026 9727806 + scaffold167 277474 276694 - 573 190 3 Glu21(11.1%),His43(22.3%)
Sl_Aki-106 His:27.44% RR-2 17 none 9 mRNA 9733252 9734211 + scaffold167 271248 270289 - 546 181 3 His(H)46(25.41%);Glu(E)20(11.05%);Gly(G)13(7.18%);Asp(D)13(7.18%);
Sl_Aki-107 His:25.53% RR-2 0 SWUSl10008098 SWUSl0043130 9 mRNA 9737350 9738084 - scaffold167 266416 267150 + 426 141 3 His(H)36(25.53%);Glu(E)19(13.48%);Lys(K)13(9.22%);Asp(D)11(7.80%);Gly(G)10(7.09%);
Sl_Aki-108 His:15.56% RR-2 16 none 9 mRNA 9739557 9740163 + scaffold167 264943 264337 - 321 106 3 Val11(10.4%),Lys11(10.4%),His14(13.2%)
Sl_Aki-109 His:19.27% RR-2 18 SWUSl10008097 SWUSl0043140 9 mRNA 9741232 9742572 + scaffold167 263268 261928 - 384 127 3 His(H)21(16.54%);Lys(K)18(14.17%);Val(V)12(9.45%);Glu(E)9(7.09%); Tyr(Y)9(7.09%)
Sl_Aki-110 His:13.51% RR-2 17 none 9 mRNA 9743860 9744830 - scaffold167 259670 260640 + 324 128 3 Ala13(10.2%),Val13(10.2%),His15(11.7%)
Sl_Aki-111 His:14.56% RR-2 17 none 9 mRNA 9745733 9746282 + scaffold167 258767 258218 - 363 120 3 Val10(10.0%),Lys10(10.0%),His15(12.5%)
Sl_Aki-112 His:14.77% RR-2 17 none 9 mRNA 9749060 9749544 - scaffold167 254956 255440 + 318 105 3 Val11(10.5%),Lys10(10.5%),His13(12.4%)
Sl_Aki-113 His:15.31% RR-2 18 SWUSl10008096 SWUSl0043160 9 mRNA 9750731 9751393 + scaffold167 253769 253107 - 351 116 3 His(H)15(12.93%);Val(V)14(12.07%);Lys(K)11(9.48%);Ala(A)10(8.62%);
Sl_Aki-114 His:14.77% RR-2 17 none 9 mRNA 9755348 9755929 - scaffold167 248571 249152 + 318 105 3 Val12(11.4%),Lys11(10.5%),His13(12.4%)
Sl_Aki-115 His:17.86% RR-2 18 none 9 mRNA 9757143 9757939 + scaffold167 247357 246561 - 309 102 3 Val11(10.8%),Lys10(9.8%),His15(14.7%)
Sl_Aki-116 His:12.71% RR-2 17 none 9 mRNA 9761095 9761785 - scaffold167 242715 243405 + 408 135 3 Val10(10.1%),Lys11(11.1%),His13(13.1%)
Sl_Aki-117 His:15.66% RR-2 16 none 9 mRNA 9762461 9763124 + scaffold167 242039 241376 - 300 99 3 Lys11(9.8%),His26(23.2%)
Sl_Aki-118 His:26.97% RR-2 23 none 9 mRNA 9764501 9765421 + scaffold167 239999 239079 - 339 112 3 Lys11(9.8%),His26(23.2%)
Sl_Aki-119 His:20.79% RR-2 18 none 9 mRNA 9766608 9767191 + scaffold167 237892 237309 - 360 119 3 His(H)21(17.65%);Val(V)13(10.92%);Gly(G)10( 8.40%); Glu(E)10(8.40%);Lys(K) 9( 7.56%);Tyr(Y) 9(7.56%)
Sl_Aki-120 His:29.89% RR-2 25 none 9 mRNA 9775422 9776234 + scaffold167 229078 228266 - 339 112 3 Val13(11.6%),His27(24.1%)
Sl_Aki-121 His:22.12% RR-2 17 SWUSl10008092 SWUSl0043190 9 mRNA 9778313 9779286 + scaffold167 226187 225214 - 321 119 3 His(H)23(19.01%);Val(V)12(9.92%);Gly(G)10(8.26%);Lys(K) 10(8.26%);
Sl_Aki-122 His:11.2% RR-2 none 9 mRNA 9780884 9781703 + scaffold167 223616 222797 - 324 107 3 Val11(10.3%),Lys11(10.3%),His12(11.2%)
Sl_Aki-123 His:27.78% RR-2 17 none 9 mRNA 9783275 9784013 + scaffold167 221225 220487 - 324 107 3 Val10(9.4%),Lys10(9.4%),His25(23.4%)
Sl_Aki-124 His:17.05% RR-2 19 none 9 mRNA 9786680 9787265 + scaffold167 217820 217235 - 324 107 3 Lys11(10.8%),His15(14.0%)
Sl_Aki-125 His:25.0% RR-2 18 none 9 mRNA 9788440 9788909 + scaffold167 216060 21559 - 318 105 3 Val11(10.5%),Lys10(10.5%),His13(12.4%)
Sl_Aki-126 His:23.81% RR-2 18 none 9 mRNA 9792226 9792751 + scaffold167 212274 211749 - 309 102 3 Gly12(11.8%),Val12(11.8%),Asp10(9.8%),His20(19.6%)
Sl_Aki-127 His:22.97% RR-2 17 none 9 mRNA 9794161 9794857 + scaffold167 210339 209643 - 498 165 3 His-rich(20.6%);Lys(K)18(10.91%);Val(V) 12(7.27%)
Sl_Aki-128 His:21.35% RR-2 18 none 9 mRNA 9796621 9797011 + scaffold167 207879 207489 - 324 107 2 Gly11(10.3%),Val15(14.0%),Asp12(11.2%),His19(17.8%)
Sl_Aki-129 His:20.90% RR-2 0 none 9 mRNA 9799406 9800205 + scaffold167 205094 204295 - 405 134 3 His(H)28(20.90%);Glu(E)15(11.19%);Lys(K)16(11.94%);Val(V)10(7.46%)
Sl_Aki-130 His:25.0% RR-2 17 none 9 mRNA 9800893 9801344 + scaffold167 203607 203156 - 306 101 3 Gly11(10.9%),Val13(12.9%),Asp11(10.9%),His21(20.8%)
Sl_Aki-131 His:25.0% RR-2 18 none 9 mRNA 9805333 9805804 + scaffold167 199167 198696 - 309 102 3 Gly11(10.8%),Val12,Asp11(10.8%),His21(20.6%)
Sl_Aki-132 His:11.5% RR-2 0 none 9 mRNA 9806788 9807299 + scaffold167 197712 197201 - 369 122 3 His-rich;His14(11.5%)
Sl_Aki-133 His:25.0% RR-2 18 none 9 mRNA 9809525 9810073 + scaffold167 194975 194427 - 309 102 3 Gly11(10.8%),Asp11(10.8%),His21(20.6%)
Sl_Aki-134 His:22.46% RR-2 17 none 9 mRNA 9811252 9812131 + scaffold167 193248 192369 - 468 155 3 Lys17(11.0%),His31(20.0%)
Sl_Aki-135 His:22.62% RR-2 18 none 9 mRNA 9813549 9814451 + scaffold167 190951 190049 - 306 102 3 Val12(11.8%),Asp11(10.8%),His19(18.6%)
Sl_Aki-136 His:15.33% RR-2 17 none 9 mRNA 9815800 9816562 - scaffold167 187938 188700 + 465 154 3 His(H)21(13.64%);Lys(K)19(12.34%);Glu(E)17(11.04%); Val(V)13(8.44%);Ser(S)13( 8.44%);
Sl_Aki-137 His:13.1% RR-2 0 none 9 mRNA 9818757 9819124 + scaffold167 185743 185376 - 369 122 3 Ala13(10.7%),His16(13.1%)
Sl_Aki-138 His:12.42% RR-2 0 SWUSl10008089 SWUSl0043200 9 mRNA 9820240 9820978 + scaffold167 184260 183522 - 462 153 3 Ala(A)33(21.57%);Val(V)21(13.73%);His(H)19(12.42%);Ser(S)12(7.84%);Pro(P)10(6.54%)
Sl_Aki-139 His:13.33% RR-2 0 SWUSl10008088 SWUSl0043150 9 mRNA 9823079 9823953 - scaffold167 180547 181421 + 498 165 3  Ala(A)34(20.61%);His(H)22(13.33%);Val(V)21(12.73%);Ser(S)18(10.91%);
Sl_Aki-140 His:12.05% RR-2 17 SWUSl10008087 SWUSl0043210 9 mRNA 9827011 9827737 - scaffold167 176763 177489 + 552 183 3 Ala(A)43(23.50%);Val(V)24(13.11%);His(H)20(10.93%);Ser(S)16(8.74%);Pro(P)12(6.56%)
Sl_Aki-141 His:10.74% RR-2 17 SWUSl10008086 SWUSl0043220 9 mRNA 9837038 9837924 + scaffold167 167462 166576 - 501 166 3 Ala(A)35(21.08%);Val(V)20(12.05%);Ser(S)17(10.24%);His(H)16(9.64%)
Sl_Aki-142 His:8.89% RR-2 0 SWUSl10008085 SWUSl0043230 9 mRNA 9840489 9841287 + scaffold167 164011 163213 - 543 180 2 Ala(A)45(25.00%);Val(V)20(11.11%);His(H)16(8.89%); Tyr(Y)14(7.78%);Pro(P)13(7.22%);Ser(S)13(7.22%);
Sl_Aki-143 His:10.34% RR-2 0 none SWUSl0043230 9 mRNA 9843607 9844243 + scaffold167 160893 160257 - 465 154 3 Ala(A)27(18.62%);Val(V)18(12.41%);His(H)15(10.34%);Ser(S)14(9.66%);Pro(P)11(7.59%);11(7.59%)
Sl_Aki-144 His:10.00% RR-2 0 SWUSl10008085 SWUSl0043230 9 mRNA 9846292 9847177 + scaffold167 158208 157323 - 483 160 3 Ala(A)32(20.00%);Ser(S)20(12.50%);Val(V)19(11.88%);His(H)16(10.00%); Tyr(Y)12(7.50%)
Sl_Aki-145 His:10.33% RR-2 0 SWUSl10008085 SWUSl0043230 9 mRNA 9851576 9852466 + scaffold167 152924 152034 - 555 184 3 Ala(A)42(22.83%);Val(V)22(11.96%);Ser(S)19(10.33%);His(H)19(10.33%);Pro(P)14(7.61%);Tyr(Y)13(7.07%)
Sl_Aki-146 His:9.29% RR-2 0 SWUSl10008084 SWUSl0043240 9 mRNA 9855178 9855983 + scaffold167 149322 148517 - 552 183 3  Ala(A)43(23.50%);Ser(S)22(12.02%);Val(V)20(10.93%);His(H)17(9.29%);Pro(P)13(7.10%);
Sl_Aki-147 His:10.34% RR-2 0 SWUSl10008083 SWUSl0043250 9 mRNA 9858097 9858915 - scaffold167 145585 146403 + 438 145 3 Ala(A)32(22.07%);Ser(S)17(11.72%);Val(V)16(11.03%);His(H)15(10.34%)
Sl_Aki-148 His:7.85% RR-2 17 SWUSl10008082 SWUSl0043260 9 mRNA 9860394 9861111 + scaffold167 144106 143389 - 627 203 2 Ala(A)57(27.40%);Val(V)29(13.94%);Pro(P)16(7.69%);His(H)15(7.21%);Tyr(Y)15(7.21%)
Sl_Aki-149 His:9.38% RR-2 17 SWUSl10008081 SWUSl0043270 9 mRNA 9862439 9863632 + scaffold167 142061 140868 - 342 113 3 Lys(K)10(8.85%);Asp(D)9(7.96%);His(H)9(7.96%); Tyr(Y)9(7.96%);Gly(G)8(7.08%);Ile(I)8( 7.08%);Glu(E)8(7.08%);
Sl_Aki-150 His:15.27% RR-2 17 SWUSl10008080 SWUSl0043280 9 mRNA 9869750 9870613 + scaffold167 134750 133887 - 447 148 3 Ala(A)23(15.54%);His(H)20(13.51%);Ser(S) 11(7.43%);Pro(P)11(7.43%);
Sl_Aki-151 His:10.26% RR-2 17 SWUSl10008079 SWUSl0043290 9 mRNA 9877945 9880193 + scaffold167 126555 124307 - 522 173 3 Val(V)19(10.98%);Gln(Q)18(10.40%);His(H)17(9.83%);Ala(A)16(9.25%);
Sl_Aki-152 His:9.83% RR-2 0 none 9 mRNA 9880360 9881280 + scaffold167 124140 123220 - 327 158 3 Ala23(21.3%),Val19(17.6%),Pro13(12.0%),His13(12.0%)
Sl_Aki-153 His:6.7% RR-2 0 none 9 mRNA 9887291 9888615 + scaffold167 117209 115885 - 315 104 3 Asp12(11.5%),His7(6.7%)
Sl_Aki-154 RR-2 21 SWUSl10008077 SWUSl0043310 9 mRNA 9896671 9897329 + scaffold167 107829 107171 - 501 166 3 Val(V)21(12.65%);Ser(S)16(9.64%);Pro(P)15(9.04%);Tyr(Y)15(9.04%); Ala(A)13(7.83%);Gly(G)12(7.23%)
Sl_Aki-155 His:15.86% RR-2 17 SWUSl10008076 SWUSl0043320 9 mRNA 9905769 9906596 + scaffold167 98731 97904 - 489 162 4 Ala(A)34(20.99%);His(H)23(14.20%);Val(V)17(10.49%);Tyr(Y)14(8.64%);
Sl_Aki-156 His:14.48% RR-2 17 none SWUSl0043320 9 mRNA 9910364 9911098 + scaffold167 94136 93402 - 489 162 4 Ala(A)30(18.52%);His(H)21(12.96%);Tyr(Y)16(9.88%);Val(V)13(8.02%);Ser(S)13(8.02%);Pro(P)12(7.41%)
Sl_Aki-157 His:14.52% RR-2 17 SWUSl10008075 SWUSl0043330 9 mRNA 9913755 9914371 + scaffold167 90745 90129 - 426 141 3 Ala(A)25(17.73%);His(H)18(12.77%);Val(V)13(9.22%);Asp(D)11(7.80%);Tyr(Y)11(7.80%);
Sl_Aki-158 His:19.33% RR-2 17 none 9 mRNA 9917125 9917835 + scaffold167 87375 86665 - 411 136 4 His(H)23(16.91%);Ala(A)16(11.76%);Val(V)12(8.82%);Asp(D)12(8.82%);Ser(S)11(8.09%)
Sl_Aki-159 His:13.46% RR-2 17 none SWUSl0043330 9 mRNA 9921102 9921890 + scaffold167 83398 82610 - 522 173 4 Ala(A)33(19.08%);His(H)21(12.14%);Val(V)15(8.67%);Tyr(Y)15(8.67%);Ser(S)14(8.09%)
Sl_Aki-160 His:11.72% RR-2 17 none 9 mRNA 9924175 9924810 + scaffold167 80325 79690 - 438 145 3 Ala23(21.3%),Val19(17.6%),Pro13(12.0%),His13(12.0%)
Sl_Aki-161 His:9.7% RR-2 17 SWUSl10008074 SWUSl0043340 9 mRNA 9928167 9928948 + scaffold167 76333 75552 - 456 151 3 Ala(A)28(18.54%); Tyr(Y)18(11.92%);Gly(G)16(10.60%);Asp(D)14(9.27%);His(H)13(8.61%);Val(V)11(7.28%);Pro(P)11(7.28%)
Sl_Aki-162 His:13.33% RR-2 17 none 9 mRNA 9932158 9932832 + scaffold167 72342 71668 - 504 167 3 Val(V)20(11.98%);His(H)20(11.98%);Ser(S)14(8.38%);Gly(G)12(7.19%);Tyr(Y)12(7.19%)
Sl_Aki-163 His:16.48% RR-2 17 SWUSl10008073 SWUSl0043350 9 mRNA 9938646 9939585 + scaffold167 65854 64915 - 582 193 4 Ala(A)42(21.76%);His(H)29(15.03%);Val(V)26(13.47%);Pro(P)18(9.33%)
Sl_Aki-164 His:26.4% RR-2 16 none 9 mRNA 9950409 9951839 + scaffold167 54091 52661 - 426 141 3 Pro15(10.6%),His34(24.1%)
Sl_Aki-165 His:17.48% RR-2 17 none 9 mRNA 9954895 9955934 + scaffold167 49605 48566 - 363 120 3 His-rich;His18(15.0%)
Sl_Aki-166 His:30.14% RR-2 28 none 9 mRNA 9965183 9966319 + scaffold167 39317 38181 - 525 174 3 His-rich;His45(25.9%)
Sl_Aki-167 His:6.06% RR-2 22 none 9 mRNA 9967785 9969149 - scaffold167 35351 36715 + 366 121 3 Ala12(9.9%),Val12(9.9%),His8(6.6%)
Sl_Aki-169 RR-2 16 none 9 mRNA 9983764 9987488 + scaffold167 20736 17012 - 1401 466 3 Ala85(18.2%),Val47(10.1%),Ser71(15.2%),His14(3.0%)
Sl_Aki-170 RR-1 18 SWUSl10014762 SWUSl0043920 9 mRNA 11822991 11829529 + scaffold24 870213 863675 - 1206 401 7 Gly45(11.2%),Pro45(11.2%),Ser37(9.2%);Asp(D)38(9.48%)
Sl_Aki-171 CPAP1-H 30 10012959 SWUSl0045030 10 mRNA 808715 824379 - scaffold54 641474 657138 + 3240 1079 7 CBM_14 [118-170]; ChtBD2 [116-162]
Sl_Aki-172 CPAP1-F 0 10012958 SWUSl0045040 10 mRNA 890758 898159 - scaffold54 567694 575095 + 414 137 4 CBM_14 [55-105]; ChtBD2 [53-105]
Sl_Aki-173 CPAP1-N 30 10012955 SWUSl0045060 10 mRNA 987068 991745 - scaffold54 474108 478785 + 936 311 4 CBM_14 [67-129]; ChtBD2 [65-245]
Sl_Aki-174 CPCFC 14 SWUSl10009335 SWUSl0045730 10 mRNA 2398790 2399979 + scaffold132 33135 34324 + 261 86 3 Ala15(17.4%),Pro18(20.9%)
Sl_Aki-175 His:8.7% CPAP1-D 17 10009369 SWUSl0046060 10 mRNA 3059121 3063979 - scaffold132 693466 698324 - 330 109 4 CBM_14 [49-100]; ChtBD2 [47-96]
Sl_Aki-176 His:9.13% CPH 15 SWUSl10008269 SWUSl0046750 10 mRNA 6368305 6369255 + scaffold161 41460 42410 + 771 256 2 Ala90(35.1%),Val24(9.4%),His22(8.6%)
Sl_Aki-177 His:16.84% CPH 15 SWUSl10008270 SWUSl0046760 10 mRNA 6388849 6390276 + scaffold161 62004 63431 + 864 287 2 Ala65(22.7%),Val30(10.5%)
Sl_Aki-178 His:6.52% CPH 0 SWUSl10008271 SWUSl0046770 10 mRNA 6413900 6414472 + scaffold161 87055 87627 + 573 190 1 Ala54(28.4%)
Sl_Aki-179 His:10.08% RR-2 18 none 11 mRNA 5836636 5837922 + scaffold150 578536 579822 + 342 113 3 Gly17(15.0%),Val13(11.5%),His16(14.2%),Tyr15(13.3%); 
Sl_Aki-180 RR-1 17 SWUSl10008643 SWUSl0049030 11 mRNA 5566328 5567025 + scaffold150 308228 308925 + 330 109 3 Ala12(11.0%),Gln11(10.1%),Glu7(6.4%)；Val(V)9(8.26%)
Sl_Aki-181 CPH 18 SWUSl10012743 SWUSl0051830 11 mRNA 12161241 12164064 + scaffold56 815249 818072 + 444 147 3 Val30(20.4%),Pro25(17.0%),Lys15(10.2%),His13(8.8%)
Sl_Aki-182 RR-1 0 SWUSl10006987 SWUSl0057380 13 mRNA 2126861 2131989 + scaffold204 231198 236326 + 516 171 6 Gln24(14.0%),Ala&Leu16(9.4%),Pro16(9.4%)
Sl_Aki-183 CPT 21 SWUSl10002405 SWUSl0062550 14 mRNA 7901834 7905025 - scaffold488 187235 184044 - 573 190 3 Pro42(22.1%);Ala(A)20(10.53%);Val(V)19(10.00%);Ser(S) 15( 7.89%)Sl_Aki-184 His:11.05% CPG 15 SWUSl10009253 SWUSl0065560 14 mRNA 15605510 15606251 - scaffold134 34616 35357 + 618 205 2 Ser31(15.1%)Gly47(22.7%),His22(10.7%)
Sl_Aki-185 RR-2 0 SWUSl10010664 SWUSl0067230 15 mRNA 4870821 4871625 + scaffold102 1058120 1058924 + 507 168 2 Gly(G)34(20.24%);Ala(A)26(15.48%);Leu(L)16(9.52%);Val(V) 15(8.93%)
Sl_Aki-186 RR-2 17 SWUSl10012083 SWUSl0070260 15 mRNA 11245841 11246561 - scaffold70 284228 283508 - 405 134 2 Ala28(20.9%),Tyr13(9.7%);Ser(S)13(9.70%);
Sl_Aki-187 RR-2 17 none 15 mRNA 11310517 11311066 + scaffold70 348184 348733 + 375 124 2 Ala25(20.2%),Tyr12(9.7%);Val(V)10(8.06%)
Sl_Aki-188 His:9.77% RR-2 17 none 15 mRNA 11314116 11314987 - scaffold70 352654 351783 - 576 191 2 Gly21(11.0%),Ala51(26.7%),Val22(11.5%),His17(8.9%)
Sl_Aki-189 His:10.38% RR-2 17 none 15 mRNA 11317727 11318725 + scaffold70 355394 356392 + 603 200 2 Gly24(12.0%),Ala53(26.0%),Val20(10.0%),His19(9.6%),Tyr16(8.0%)
Sl_Aki-190 His:9.71% RR-2 17 SWUSl10012085 SWUSl0070290 S 15 mRNA 11322840 11323823 + scaffold70 360507 361490 + 579 192 2 Gly24(12.5%),Ala49(25.5%),Val(V)19(9.90%);His17(8.9%),Tyr16(8.3%)
Sl_Aki-191 His:8.77% RR-2 17 SWUSl10012086 SWUSl0070300 15 mRNA 11325089 11326311 - scaffold70 363978 362756 - 1080 359 2 Gly61(17.0%),Ala79(22.0%),Pro45(12.8%),His30(8.4%),Tyr22(6.1%)
Sl_Aki-192 RR-2 19 SWUSl10012087 SWUSl0070310 15 mRNA 11328621 11330078 + scaffold70 366288 367745 + 828 275 2 Gly(G)48(17.45%);Ala(A)44(16.00%);Asn(N)29(10.55%);Val(V)24(8.73%);Ser(S)24(8.73%)
Sl_Aki-193 RR-2 17 SWUSl10012088 SWUSl0070320 15 mRNA 11337706 11338443 + scaffold70 375373 376110 + 525 174 2 Ala(A)49(28.16%);Val(V)28(16.09%);Pro(P)13(7.47%) 
Sl_Aki-194 RR-2 17 SWUSl10012089 SWUSl0070330 15 mRNA 11340851 11341695 - scaffold70 379362 378518 - 552 183 2 Ala(A)54(29.51%);Val(V)29(15.85%);Pro(P)14(7.65%);Tyr(Y)13(7.10%)
Sl_Aki-195 CPAP1-G 19 10010858 SWUSl0070610 15 mRNA 12791047 12814690 - scaffold98 456018 479661 - 948 315 6 CBM_14 [157-210]; ChtBD2 [155-204]
Sl_Aki-196 CPG 21 SWUSl10009001 SWUSl0071940 16 mRNA 2215896 2217128 + scaffold140 632994 634226 + 660 219 2 QGY repeat;Gly42(19.2%),Tyr29(13.2%)
Sl_Aki-197 CPG 19 SWUSl10003600 SWUSl0072780 16 mRNA 4701149 4703004 + scaffold388 172820 174675 + 720 239 2 Gly53(22.2%),Leu25(10.5%)
Sl_Aki-198 RR-1 18 SWUSl10013174 SWUSl0073200 16 mRNA 5333418 5336193 - scaffold50 471221 468446 - 594 197 4 Tyr20(11.7%),Lys19(9.6%)
Sl_Aki-199 CPG 0 none SWUSl0075440 16 mRNA 10487587 10488253 + scaffold207 330163 329497 - 294 97 2 Gly(G)43(44.33%);Tyr(Y)14(14.43%);Ala(A)10(10.31%);Leu(L)9(9.28%)
Sl_Aki-200 CPH 0 SWUSl10008912 SWUSl0083940 18 mRNA 4888873 4890108 - scaffold143 139508 140743 + 1194 397 2 Val95(22.5%),Ser66(16.6%),Lys44(11.1%)
Sl_Aki-201 CPG 30 SWUSl10002192 SWUSl0088820 20 mRNA 1179283 1179902 - scaffold517 112910 112291 - 537 178 2 Gly34(19.1%),Ser31(17.4%)
Sl_Aki-202 RR-2 17 none 20 mRNA 3079545 3080215 - scaffold126 650506 649836 - 585 194 2 Ala46(23.7%),Val30(15.5%),Tyr18(9.3%);Pro(P)17(8.76%)
Sl_Aki-203 His:6.78% RR-2 17 none 20 mRNA 3090897 3091546 - scaffold126 661837 661188 - 558 185 2 Ala42(22.2%),Val31(16.8%),Tyr17(9.2%); Pro(P)17(9.19%)
Sl_Aki-204 His:6.55% RR-2 17 none 20 mRNA 3093616 3094237 - scaffold126 664528 663907 - 531 176 2 Ala37(21.02%);Val(V)29(16.48%);Tyr(Y)16(9.09%);Pro(P)15(8.52%)
Sl_Aki-205 His:6.92% RR-2 17 none 20 mRNA 3096965 3097603 - scaffold126 667894 667256 - 531 176 2 Ala(A)38(21.59%);Val(V)29(16.48%);Tyr(Y)16(9.09%); Pro(P)15(8.52%)
Sl_Aki-206 His:6.92% RR-2 17 none 20 mRNA 3099923 3100564 - scaffold126 670855 670214 - 558 185 2 Ala43(23.2%),Val29(15.7%),Tyr17(9.2%);Pro(P)16(8.65%)
Sl_Aki-207 His:6.55% RR-2 17 SWUSl10009649 SWUSl0089540 20 mRNA 3101400 3102013 + scaffold126 671691 672304 + 492 163 2 Ala34(20.9%),Val24(14.7%),Tyr14(8.6%)
Sl_Aki-208 His:6.85% RR-2 17 SWUSl10009650 SWUSl0089550 20 mRNA 3109395 3110438 + scaffold126 679686 680729 + 813 270 2 Ala75(27.8%),Val38(13.3%),Tyr24(8.9%);  Pro(P)24(8.89%)
Sl_Aki-209 RR-1 16 SWUSl10010969 SWUSl0090520 20 mRNA 6877778 6881160 + scaffold95 1139422 1142804 + 567 188 3 Pro(P)17(9.04%);Tyr(Y)16(8.51%);Ala(A)15(7.98%);Thr(T)15(7.98%);Glu(E)15(7.98%);Lys(K) 15(7.98%)
Sl_Aki-210 RR-1 19 SWUSl10010970 SWUSl0090530 20 mRNA 6886598 6889678 + scaffold95 1148242 1151322 + 2820 939 4 Asn96(10.2%),Gln63(6.7%),Ser74(7.9%)
Sl_Aki-211 His:10.47% CPG 19 SWUSl10015397 SWUSl0096450 21 mRNA 13003529 13005223 - scaffold15 1203668 1205362 + 1206 401 2 Val77(19.2%),Pro67(16.7%),Lys40(10.0%),His40(10.0%)
Sl_Aki-212 His:7.35% CPG 19 SWUSl10015395 SWUSl0096470 21 mRNA 13037502 13038906 - scaffold15 1169985 1171389 + 1080 359 2 Val83(23.1%),Pro73(20.3%),Lys38(10.6%)
Sl_Aki-213 His:6.34% CPG 18 SWUSl10015394 SWUSl0096480 21 mRNA 13076032 13077578 - scaffold15 1131313 1132859 + 1098 365 2 Val79(21.6%),Pro71(19.5%)
Sl_Aki-214 RR-1 16 SWUSl10015359 SWUSl0096800 21 mRNA 13639952 13640534 + scaffold15 568939 568357 - 321 106 3 Ala17(16.0%),Val12(11.3%)
Sl_Aki-215 RR-1 16 none 21 mRNA 13644512 13645094 + scaffold15 564379 563797 - 321 106 3 Ala17(16.0%),Val12(11.3%);Gly(G)10(9.43%)
Sl_Aki-216 RR-1 16 SWUSl10015358 SWUSl0096810 21 mRNA 13657166 13658432 + scaffold15 551725 550459 - 321 106 3 Ala12(11.3%),Val16(15.1%)
Sl_Aki-217 CPAP1-B 23 10015690 SWUSl0098940 22 mRNA 4543211 4558148 + scaffold11 773261 788198 + 579 192 4 CBM_14 [100-152]; ChtBD2 [98-148[
Sl_Aki-218 CPAP1-B2 21 10015691 SWUSl0098950 22 mRNA 4566167 4590078 + scaffold11 796217 820128 + 2196 731 5 CBM_14 [561-613]; ChtBD2 [559-609]
Sl_Aki-219 RR-2 0 SWUSl10010676 SWUSl0100940 22 mRNA 12753202 12765491 + scaffold101 124784 137073 + 798 265 3 Lys30(11.3%)
Sl_Aki-220 CPG 16 SWUSl10001933 SWUSl0101330 23 mRNA 11207 11838 - scaffold550 11838 11207 - 549 182 2 Gly60(33.0%),Val22(12.1%),Ser30(16.5%),Tyr17(9.3%)
Sl_Aki-221 CPG 16 none 23 mRNA 15685 16304 - scaffold550 16304 15685 - 537 178 2 Gly58(32.6%),Val22(12.4%),Ser29(16.3%),Tyr16(9.0%)
Sl_Aki-222 CPG 16 SWUSl10001935 SWUSl0101340 23 mRNA 20737 21356 - scaffold550 21356 20737 - 537 178 2 Gly58(32.6%),Val22(12.4%),Ser29(16.3%),Tyr16(9.0%)
Sl_Aki-223 CPG 16 SWUSl10001936 SWUSl0101350 23 mRNA 25070 25987 - scaffold550 25987 25070 - 684 227 2 ;Gly34(15.0%),Ala27(11.9%),Val27(11.9%),Ser30(18.2%),Tyr22(9.1%)
Sl_Aki-224 His:15.11% CPH 17 SWUSl10001937 SWUSl0101360 23 mRNA 45858 47295 - scaffold550 47295 45858 - 1245 414 2 Ala45(10.1%),Leu54(12.4%),Pro48(11.6%),Ser111(26.8%),His60(14.5%)
Sl_Aki-225 CPG 0 SWUSl10008448 SWUSl0102380 23 mRNA 2563635 2573347 + scaffold155 431359 441071 + 1245 414 2 Val(V)78(18.84%);Gly(G)59(14.25%);Pro(P)51(12.32%);Ser(S)36(8.70%); Ala(A)31(7.49%)
Sl_Aki-226 CPG 18 SWUSl10008453 SWUSl0102410 23 mRNA 2641871 2646309 + scaffold155 509595 514033 + 684 227 2
Gly(G)36(15.86%);Val(V)36(15.86%);Pro(P)33(14.54%);Ile(I)25(11.01%);Ser(S)18
(7.93%)
Sl_Aki-227 His:8.13% CPG 19 SWUSl10015582 SWUSl0103030 23 mRNA 4707065 4708314 + scaffold12 1717766 1719015 + 1167 388 2 ;Gly74(19.1%),Val41(10.6%),Pro40(10.3%),Ser57(14.7%),His30(7.7%)
Sl_Aki-228 His:6.65% CPG 19 SWUSl10015583 SWUSl0103040 23 mRNA 4713522 4714673 + scaffold12 1724223 1725374 + 1053 350 2 Gly50(14.3%),Val48(13.7%),Pro44(12.6%),Ser40(11.4%),His22(6.3%)
Sl_Aki-229 His:14.92% CPG 15 SWUSl10015585 SWUSl0103060 23 mRNA 4724706 4725829 - scaffold12 1736530 1735407 - 591 196 2 Gly29(14.8%),Glu25(12.8%),His28(14.3%)
Sl_Aki-230 RR-1 16 SWUSl10006738 SWUSl0104090 23 mRNA 7105557 7106143 - scaffold214 115038 114452 - 837 278 1 QY/QP repeat;Pro33(11.9%),Tyr29(10.4%),Gln47(16.9%)
Sl_Aki-231 CPG 18 SWUSl10011572 SWUSl0109480 24 mRNA 11506777 11509768 - scaffold83 613494 610503 - 1047 348 6 Gly(G)46(13.22%);Lys(K)35(10.06%);Met(M)29(8.33%)
Sl_Aki-233 CPG 0 SWUSl10013852 SWUSl0110720 25 mRNA 2760059 2785770 + scaffold39 1463141 1488852 + 732 243 4 Gly(G)40(16.46%);Ala30(12.35%);Pro(P)20(8.23%);
Sl_Aki-234 CPFL 17 SWUSl10011525 SWUSl0112390 25 mRNA 8271643 8272592 + scaffold80 929084 930033 + 636 211 2 Ala81(38.4%),Ser20(9.5%),Tyr26(12.3%),Pro21(10.0%)
Sl_Aki-235 CPG 18 SWUSl10011526 SWUSl0112400 25 mRNA 8285355 8287618 + scaffold80 942796 945059 + 432 143 3 Gly31(21.7%),Ala17(11.9%),Ser18(10.6%),Tyr22(15.4%)
Sl_Aki-236 CPFL 17 SWUSl10011528 SWUSl0112410 25 mRNA 8291897 8293040 + scaffold80 949338 950481 + 942 313 2 Ala91(29.1%),Val44(14.1%),Ser45(14.4%),Tyr32(10.2%)
Sl_Aki-237 CPFL 17 SWUSl10011529 SWUSl0112420 25 mRNA 8296557 8297773 + scaffold80 953998 955214 + 747 248 2 Ala83(33.5%),Val32(12.9%),Ser29(11.7%),Tyr28(11.3%)
Sl_Aki-238 CPFL 17 none 25 mRNA 8299047 8299981 + scaffold80 956488 957422 + 642 213 2 Ala75(35.2%),Val21(9.9%),Pro20(9.4%),Tyr20(9.4%)
Sl_Aki-239 CPFL 17 SWUSl10011530 SWUSl0112430 25 mRNA 8300469 8301751 - scaffold80 959192 957910 - 630 209 2 Ala45(21.5%),Val23(11.0%),Ser37(17.7%),Tyr24(11.5%)
Sl_Aki-240 CPFL 17 SWUSl10011531 SWUSl0112440 25 mRNA 8304931 8306005 - scaffold80 963446 962372 - 813 270 2 Ala82(30.4%),Val30(11.1%),Ser44(16.3%),Tyr31(11.5%)
Sl_Aki-241 CPFL 17 SWUSl10011533 SWUSl0112460 25 mRNA 8317557 8317604 - scaffold80 975045 974998 - 813 270 2 Ala86(31.9%),Val33(12.2%),Ser31(11.5%),Tyr26(9.6%)
Sl_Aki-242 CPG 17 SWUSl10012442 SWUSl0113230 25 mRNA 10832710 10835676 - scaffold62 905683 908649 + 1245 414 3 Gly(G)89(21.50%);Glu(E)37(8.94%);Ala(A)36(8.70%);Val(V)36(8.70%);Lys(K)36(8.70%)
Sl_Aki-243 RR-2 0 SWUSl10005648 SWUSl0114190 26 mRNA 684597 695005 + scaffold260 50866 61274 + 1458 485 3 Asn(N)43(8.87%);Ser(S)39(8.04%)
Sl_Aki-245 CPH 18 SWUSl10003718 SWUSl0114520 26 mRNA 2447545 2466941 - scaffold383 211801 231197 + 3291 1096 5 Val122(12.0%),Pro110(10.0%)
Sl_Aki-246 RR-2 19 SWUSl10012781 SWUSl0115480 26 mRNA 6259743 6267836 - scaffold53 20194 12101 - 696 231 6 Gly(G)31(13.42%);Ala(A)30(12.99%)
Sl_Aki-247 RR-2 0 SWUSl10012783 SWUSl0115500 26 mRNA 6278916 6282687 - scaffold53 35045 31274 - 1623 540 5 Ser(S)113(20.93%);Pro(P)49(9.07%);Gly(G)48(8.89%)
Sl_Aki-248 His:14.17% RR-2 17 SWUSl10014164 SWUSl0115940 26 mRNA 8487170 8502996 - scaffold33 1313699 1329525 + 414 134 3 His17(12.4%),Gly(G)12(8.76%);Asn(N)12(8.76%);Ser(S)11(8.03%);Asp(D)11(8.03%)
Sl_Aki-249 RR-2 15 SWUSl10014158 SWUSl0115980 26 mRNA 8796567 8800969 + scaffold33 1020128 1015726 - 912 303 6 Gly(G)56(18.48%);Ser(S)36(11.88%);Gln(Q)33(10.89%);Ala(A)31(  10.23%);Pro(P)27(8.91%);Tyr(Y)23(7.59%)
Sl_Aki-252 RR-2 0 SWUSl10014154 SWUSl0116010 26 mRNA 8865333 8867139 + scaffold33 951362 949556 - 372 123 3 Gly(G)15(12.20%);Tyr(Y)14(11.38%); 
Sl_Aki-253 RR-2 23 SWUSl10014139 SWUSl0116170 26 mRNA 9537631 9545515 - scaffold33 271180 279064 + 1500 499 2 Gln(Q)43(8.62%) 
Sl_Aki-254 CPAP1-A 25 10003769 SWUSl0120830 27 mRNA 12342242 12363112 + scaffold377 147573 168443 - 552 183 4 CBM_14 [89-139]; ChtBD2 [85-133]
Sl_Aki-255 CPH 17 SWUSl10011693 SWUSl0124530 28 mRNA 7547384 7550278 + scaffold79 910034 907140 - 207 68 2 Tyr(Y)17(25.00%);Gly(G)12(17.65%);Ser(S)10(14.71%); Ala(A)7(10.29%);Leu(L)6(8.82%);
Sl_Aki-256 CPH 17 SWUSl10011680 SWUSl0124650 28 mRNA 7625293 7625843 + scaffold79 832125 831575 - 288 95 2 Ala33(34.8%),Val15(15.8%)；Pro(P)9(9.47%)；Ser(S)9(9.47%)
Sl_Aki-257 CPH 17 SWUSl10011679 SWUSl0124660 28 mRNA 7631214 7632834 + scaffold79 826204 824584 - 1536 511 2 Pro109(21.3%),Gln90(17.6%)；Val(V)46(9.00%)
Sl_Aki-258 CPH 16 SWUSl10011678 SWUSl0124670 28 mRNA 7636447 7636946 + scaffold79 820971 820472 - 417 138 2 Ala52(37.7%),Val20(14.5%),Pro23(16.7%)
Sl_Aki-259 CPH 17 SWUSl10011677 SWUSl0124680 28 mRNA 7642810 7643693 + scaffold79 814608 813725 - 696 231 2 Ala60(26.0%),Val28(12.6%),Pro59(25.5%)
Sl_Aki-260 CPH 18 SWUSl10011676 SWUSl0124690 28 mRNA 7645313 7646111 - scaffold79 811307 812105 + 501 166 2 Ala63(38.0%),Pro28(16.9%),Tyr14(8.4%)
Sl_Aki-261 CPH 17 SWUSl10011675 SWUSl0124700 28 mRNA 7647118 7647931 + scaffold79 810300 809487 - 333 110 2 Ala42(38.2%),Val16(14.6%),Pro15(13.6%)
Sl_Aki-262 CPH 16 SWUSl10011673 SWUSl0124720 28 mRNA 7666878 7667591 + scaffold79 790540 789827 - 714 237 1 Ala54(22.78%);Ser(S)32(13.50%);Pro(P)28(11.81%);Val(V)22(9.28%);Ile(I) 20(8.44%);Leu(L)17(7.17%)
Sl_Aki-263 CPH 16 SWUSl10011672 SWUSl0124730 28 mRNA 7670315 7670911 + scaffold79 787103 786507 - 597 198 1 Ala38(19.19%);Val(V)38(19.19%);Ser(S)35(17.68%);Pro(P)21(10.61%);Tyr(Y)17(8.59%)
Sl_Aki-264 His:15.23% CPG 23 SWUSl10011670 SWUSl0124740 28 mRNA 7672124 7673171 - scaffold79 784247 785294 + 663 220 2 Gly52(23.6%),Ala33(15.4%),Val31(14.1%),His31(14.1%);
Sl_Aki-265 CPH 16 SWUSl10011670 SWUSl0124740 28 mRNA 7675515 7676213 - scaffold79 781205 781903 + 699 232 1 Pro27(11.6%),Ser19(8.2%),Thr22(9.5%),Tyr21(9.1%)
Sl_Aki-266 CPH 16 SWUSl10011669 SWUSl0124760 28 mRNA 7682399 7682863 + scaffold79 775019 774555 - 465 154 1 Ala35(22.73%);Leu(L)22(14.29%);Pro(P)19(12.34%);Ser(S)12(7.79%);Tyr(Y)12(7.79%)
Sl_Aki-267 CPH 16 SWUSl10011668 SWUSl0124770 28 mRNA 7685604 7686071 + scaffold79 771814 771347 - 468 155 1 Ala38(24.52%);Leu(L)21(13.55%);Leu(L)21(13.55%) ;Ser(S)12(7.74%);Tyr(Y)11(7.10%)
Sl_Aki-268 CPH 16 SWUSl10011667 SWUSl0124780 28 mRNA 7688813 7689280 - scaffold79 768138 768605 + 468 155 1  Ala)37(23.87%);Leu(L)22(14.19%);Pro(P)18(11.61%);Ser(S)12(7.74%); Tyr(Y)11(7.10%)
Sl_Aki-269 His:8.24% CPH 16 SWUSl10011666 SWUSl0124790 28 mRNA 7690669 7691265 - scaffold79 766153 766749 + 597 198 1 Ala(A)48(24.24%);Leu(L)28(14.14%);Gly(G)26(13.13%);Pro(P)20(10.10%);Val(V)18( 9.09%);His(H)15(7.58%)
Sl_Aki-270 His:11.65% CPLCA 16 SWUSl10011664 SWUSl0124800 28 mRNA 7718971 7719768 + scaffold79 738447 737650 - 798 265 1 Ala(A)62(23.40%);Val(V)48(18.11%);Ser(S)27(10.19%);His(H)29(10.94%)
Sl_Aki-271 His:11.65% CPLCA 16 SWUSl10011663 SWUSl0124810 28 mRNA 7723160 7723957 + scaffold79 734258 733461 - 798 265 1 Ala(A)62(23.40%);Val(V)48(18.11%);His(H)29(10.94%);Ser(S)26(9.81%)
Sl_Aki-272 His:10.31% CPLCA 16 SWUSl10011662 SWUSl0124820 28 mRNA 7726219 7727229 - scaffold79 730189 731199 + 1011 336 1 Ala81(24.1%),Val56(16.7%),Ser34(10.1%),His33(9.8%)
Sl_Aki-273 CPLCA 16 SWUSl0124820 (117aa)SWUSl0124830 28 mRNA 7733384 7733917 - scaffold79 723501 724034 + 534 177 1 Ala39(2.0%),Val47(26.6%),Ser23(13.0%)
Sl_Aki-274 RR-1 16 SWUSl10005836 SWUSl0128320 29 mRNA 5301097 5303151 + scaffold256 47299 45245 - 411 136 2 Gly16(11.8%),Pro14(10.3%),Ser12(8.8%);Ala(A)12(8.82%)
Sl_Aki-275 RR-1 17 SWUSl10005835 SWUSl0128330 29 mRNA 5308318 5309094 + scaffold256 40078 39302 - 483 160 3 Ala22(13.8%),Ser23(14.4%);Gly(G)15(9.38%)
Sl_Aki-276 RR-1 18 SWUSl10005834 SWUSl0128340 29 mRNA 5312459 5313344 - scaffold256 35052 35937 + 465 154 3 Gly23(14.9%),Ala18(11.7%),Ser15(9.7%)
Sl_Aki-277 RR-1 17 SWUSl10005833 SWUSl0128350 29 mRNA 5320290 5321466 - scaffold256 26930 28106 + 591 196 3 Gly59(30.1%),Ser20(10.2%);Pro(P)17(8.67%)
Sl_Aki-278 His:11.59% CPH 16 SWUSl10013791 SWUSl0134550 30 mRNA 8146646 8148221 - scaffold46 1175805 1177380 + 672 223 4 Gly32(14.4%),Ala60(26.9%),His24(10.8%)
Sl_Aki-279 CPH 18 SWUSl10013761 SWUSl0134850 30 mRNA 8496564 8497675 - scaffold46 826351 827462 + 735 244 2 Ala64(26.2%),Pro25(10.3%),Asn22(9.0%),Gln24(9.8%)
Sl_Aki-280 CPH 17 none scaffold3mRNA 2232829 2233456 + scaffold3 2232829 2233456 + 288 95 2 Ala33(34.8%),Val15(15.8%),Pro9(9.5%),Tyr8(8.4%),Ser8(8.4%)
Sl_Aki-281 His:6.32% CPG 20 SWUSl10003535 SWUSl0138490 scaffold403mRNA 73598 72954 - scaffold403 73598 72954 - 348 115 2 Gly34(33.9%)
Sl_Aki-282 His:6.28% RR-2 17 SWUSl10001028 SWUSl0145410 scaffold704mRNA 21233 20423 - scaffold704 21233 20423 - 675 224 2 Ala59(26.3%),Val42(18.8%),Pro(P)22(9.82%);Tyr17(7.6%)
Sl_Aki-283 RR-2 17 SWUSl10001029 SWUSl0145420 scaffold704mRNA 42432 43578 + scaffold704 42432 43578 + 987 328 2 Ala115(35.06%);Val(V)45(13.72%);Pro(P)35(10.67%)
Sl_Aki-284 RR-2 17 SWUSl10001030 SWUSl0145430 scaffold704mRNA 47760 48751 + scaffold704 47760 48751 + 810 269 2 Ala95(36.3%),Val43(16.0%),Pro27(10.0%),Tyr19(7.1%)
Sl_Aki-285 RR-2 16 SWUSl10001031 SWUSl0145440 scaffold704mRNA 52976 54002 + scaffold704 52976 54002 + 429 142 2 Ala24(16.9%),Val21(14.8%),Pro18(12.7%),Tyr8(5.6%)
Sl_Aki-286 RR-2 17 SWUSl10001032 SWUSl0145450 scaffold704mRNA 54811 55513 + scaffold704 54811 55513 + 612 203 2 Ala46(22.7%),Val32(15.8%),Pro(P)18(8.87%);Tyr17(8.4%)
Sl_Aki-287 RR-2 0 SWUSl10001034 SWUSl0145470 scaffold704mRNA 60176 61315 - scaffold704 61315 60176 - 495 164 2 Ala45(27.44%);Val(V)21(12.80%);Pro(P)16(9.76%)
Sl_Aki-288 His:7.98% RR-2 17 SWUSl10001034 SWUSl0145470 scaffold704mRNA 62599 63449 - scaffold704 63449 62599 - 618 205 2 Ala59(25.9%),Val37(18.1%),Pro(P)18(8.78%);His(H)15(7.32%) ;Tyr18(6.8%)
Sl_Aki-289 His:6.91% RR-2 17 SWUSl10001035 SWUSl0145480 scaffold704mRNA 64312 65683 + scaffold704 64312 65683 + 618 205 2 Ala(A)54(26.34%);Val(V)38(18.54%);Pro(P)18(8.78%);Tyr(Y)17( 8.29%)
Sl_Aki-290 CPAP3-E4 0 10000546r2 SWUSl0148690r scaffold935292 10745 - scaffold935 9292 10745 - 699 232 6 CBM_14 [35-85][102-154][182-225]; ChtBD2 [35-74][102-148[]182-217]
Sl_Aki-291 CPH 17 none scaffold2509mRNA 1527 2112 + scaffold2509 1527 2112 + 288 95 2 Ala33(34.8%),Val15(15.8%),Pro9(9.5%),Tyr8(8.4%),Ser8(8.4%)
Sl_Aki-292 CPT 0 SWUSl10011300 SWUSl0002530  Z mRNA 9768016 9768665 - scaffold88 1145548 1144899 - 621 206 2 Gly-rich 49(23.8%)；Pro(P)26(12.62%);Ile(I)23(11.17%)
Sl_Aki-293 CPT 0 SWUSl10011304 SWUSl0002560  Z mRNA 9840233 9841554 - scaffold88 1218437 1217116 - 1008 335 2 Ser(S)60(17.91%);Asn(N)31(9.25%);Pro(P)28(8.36%)
Sl_Aki-294 CPT 0 SWUSl10013674 SWUSl0002810  Z mRNA 10587252 10588575 + scaffold40 1214805 1213482 - 672 223 2 Ser(S)37(16.59%);Pro(P)23(10.31%);Val(V)21(9.42%)
Sl_Aki-CPF CPF SWUSl0111680 SWUSl0111680 25 mRNA 6327454 6337568 - scaffold437 35612 45726 - 441 146 4 Ala(A)22(15.07%); Ser(S)17(11.64%); Leu(L)16(10.96%);Val(V)14(9.59%)
L1D2_EP(whole) L2D2_EP(whole) L3D2_EP L4D2_EP L5D2_EP L6D2_EP_D L6D2_EP_N W_EP_D W_EP_N P2_EP P2_Wg P6_EP P6_Wg P9_EP P9_Wg P12_EP P12_Wg
RR-1(63) 41 59 42 48 45 51 45 31 22 35 31 17 26 33 17 39 35
RR-2(129) 26 91 28 33 30 41 40 32 32 38 30 20 32 50 44 60 62
RR-3(1) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1
CPG(28) 16 22 18 17 19 18 19 16 20 17 20 20 18 20 20 18 22
CPH(26) 11 21 12 17 14 18 16 11 12 16 14 13 16 13 10 17 16
CPAP1(13) 6 12 9 5 4 7 8 6 8 10 8 7 8 13 13 13 12
CPAP3(9) 8 8 8 8 8 8 8 7 6 7 7 6 7 7 6 7 7
CPFL(7) 4 6 4 5 4 5 6 1 2 7 6 1 3 6 2 7 6
CPLCA(4) 3 4 4 4 4 4 4 0 3 4 4 0 3 3 2 4 4
CPT(5) 5 5 4 3 4 4 3 4 4 3 2 3 2 3 3 4 4
CPF(1) 1 0 1 0 0 0 1 0 1 1 1 1 1 1 1 1 1
CPCFC(1) 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1
Total(287) 123 230 132 142 133 158 152 110 112 140 125 90 118 151 119 172 171
Supplementary Table 2.  Numbers of genes from each CP group  expressed per library
L1D2_EP(whole) L2D2_EP(whole) L3D2_EP L4D2_EP L5D2_EP L6D2_EP_D L6D2_EP_N W_EP_D W_EP_N P2_EP P2_Wg P6_EP P6_Wg P9_EP P9_Wg P12_EP P12_Wg
RR-1 116705 278947 82667 355390 268002 455408 462561 26954 26775 31679 1660 1890 2669 42854 14808 58283 11567
RR-2 348 49969 569 2478 377 8517 5084 992 999 11732 1051 3025 5340 134920 184337 129479 162394
RR-3 642 303 1087 1332 949 1245 1443 635 207 2541 293 10 4 4 0 85 7
CPG 22935 116540 10206 4550 4322 3499 3163 3068 5817 2265 2335 120649 147493 93050 214203 118529 162159
CPH 149 25029 647 7192 1269 11518 8751 799 5365 315771 109135 3238 1526 327068 64099 102801 39777
CPAP1 203 882 1494 192 135 221 226 2348 5271 339 147 646 746 4272 4208 13776 25131
CPAP3 1271 21586 3937 3601 1572 8445 6543 2515 2740 2654 2432 27230 31503 24499 13611 81304 8913
CPFL 17 6231 29 181 18 1072 793 39 47 6635 653 35 143 4787 16926 37249 51676
CPLCA 129 3625 325 1900 713 2035 1356 0 18 1334 161 0 12 42 15 3628 233
CPT 8404 66386 10511 4451 3861 2222 934 65 1615 16 16 82 21 25446 2762 4573 1563
CPF 4 0 10 0 0 0 3 0 8 2 2 8 5 4 29 421 856
CPCFC 0 145 3 382 0 177 226 136 117 27017 327 144 40 56928 11963 1009 456
Total 150807 569643 111485 381649 281218 494359 491083 37551 48979 401985 118212 156957 189502 713874 526961 551137 464732







Supplementary Figure1. Expansion of RR-1 CP gene cluster on Chr1 in 

































Supplementary Figure 2. The phylogenetic tree of CPFL CPs of 
S. litura, M. sexta and B. mori. Five CPFL CPs formed a species




































































































































































Larval stage W stage Pupal stage Pupal Adult
SupplePeQtar\ Figure 3. CPs showiQg low e[pressoQ iQ Post RNA-seT liEraries. 
























































































































































































































































SupplePeQtar\ Figure 4. S. litura CP traQsFripts heatPap. S. litura CPs were













































































































































































































Supplementary Figure 5. Heatmap of transcripts of all the other CP genes of S. litura 
not shown in Fig. 6, Supplementary Fig. S3 and S4.
